<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://fn.bmj.com">
<title>FN Online First</title>
<link>http://fn.bmj.com</link>
<description>FN RSS Feed -- Online First</description>
<prism:eIssn>1468-2052</prism:eIssn>
<prism:publicationName>Archives of Disease in Childhood - Fetal and Neonatal Edition</prism:publicationName>
<prism:issn>1359-2998</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301158v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301126v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300631v2?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300752v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300763v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300578v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300969v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301090v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300716v2?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300244v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301388v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300907v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301507v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301200v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301235v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301464v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301209v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300412v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300405v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301008v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301016v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301096v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300773v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300094v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300872v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300929v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300888v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301148v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301041v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301317v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301480v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300117v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300381v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300822v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301251v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300097v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300336v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300601v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300532v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300557v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300647v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300548v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300356v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300627v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300838v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300295v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300213v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300121v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300235v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300573v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300635v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.300492v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.300224v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.212001v2?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300143v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300641v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300535v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.215160v2?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.209700v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.196451v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.213587v2?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300357v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.210740v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.210856v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.214239v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.211318v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.213702v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.206102v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300277v2?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.204735v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.199703v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.207043v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.208868v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.194100v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2009.170910v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.205864v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.211649v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.190173v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2009.180091v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.188359v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.190157v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2009.175109v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2007.120709v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.183863v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2009.178723v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2009.180869v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2008.137125v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2006.114009v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2006.105577v1?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif" />
</channel>
<image rdf:about="http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif">
<title>Archives of Disease in Childhood - Fetal and Neonatal Edition</title>
<url>http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif</url>
<link>http://fn.bmj.com</link>
</image>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301158v1?rss=1">
<title><![CDATA[Improved radiological assessment of neonatal feeding tubes]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301158v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>In about one-fifth of radiographs performed in neonates, no exact gastric feeding tube position can be defined.</p></sec><sec><st>Objectives</st><p>To determine whether injection of air via feeding tube before taking radiographs improves radiological assessment of its position.</p></sec><sec><st>Methods</st><p>In the study group (n=153), air was injected via gastric feeding tube before taking a radiograph. The tube position on radiographs was compared with a blinded control group (n=381) with no injection of air.</p></sec><sec><st>Results</st><p>The definition of exact gastric tube position was possible in 95% of the study group compared with 78% in the control group (p&lt;0.001).</p></sec><sec><st>Conclusion</st><p>Injection of air before taking a radiograph significantly improves the definition of exact gastric feeding tube position in neonates.</p></sec>]]></description>
<dc:creator><![CDATA[Quandt, D., Brons, E., Schiffer, P. M., Schraner, T., Bucher, H. U., Mieth, R. A.]]></dc:creator>
<dc:date>2012-02-06T22:24:07-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301158</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301158</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[Improved radiological assessment of neonatal feeding tubes]]></dc:title>
<prism:publicationDate>2012-02-06</prism:publicationDate>
<prism:section>Short research reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301126v1?rss=1">
<title><![CDATA[Congenital dislocation of the knee]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301126v1?rss=1</link>
<description><![CDATA[<p>The neonatal senior house officer was called to attend a delivery of a term infant due to the presence of meconium-stained liquor. Antenatal scans had been normal, and the pregnancy was unremarkable. A baby girl was delivered by spontaneous vertex delivery in good condition. However, on initial assessment, it was noticed that her left leg was hyperextended to 120&deg; and the lower leg was facing outwards. The leg was moving actively and the knee could be passively flexed to 90&deg;. The knee was not tender or swollen. Further examination revealed a dislocatable left hip, but the rest of her systemic and musculoskeletal examinations were normal.</p><p>Congenital dislocation of the knee is a rare condition affecting 1 in 100 000 babies. It is more common in females and breech presentations. It can be associated with orthopaedic conditions including developmental dysplasia of the hip and talipes equinovarus. It can also be found with...]]></description>
<dc:creator><![CDATA[Mottershead, N. J., Patel, U. D., Reynolds, P.]]></dc:creator>
<dc:date>2012-02-03T01:23:58-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301126</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301126</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Pregnancy, Reproductive medicine, Rheumatology, Sexual health, Dermatology, Competing interests (ethics), Trauma, Injury]]></dc:subject>
<dc:title><![CDATA[Congenital dislocation of the knee]]></dc:title>
<prism:publicationDate>2012-02-03</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300631v2?rss=1">
<title><![CDATA[Epidemiology of small intestinal atresia in Europe: a register-based study]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300631v2?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>The epidemiology of congenital small intestinal atresia (SIA) has not been well studied. This study describes the presence of additional anomalies, pregnancy outcomes, total prevalence and association with maternal age in SIA cases in Europe.</p></sec><sec><st>Methods</st><p>Cases of SIA delivered during January 1990 to December 2006 notified to 20 EUROCAT registers formed the population-based case series. Prevalence over time was estimated using multilevel Poisson regression, and heterogeneity between registers was evaluated from the random component of the intercept.</p></sec><sec><st>Results</st><p>In total 1133 SIA cases were reported among 5126, 164 registered births. Of 1044 singleton cases, 215 (20.6%) cases were associated with a chromosomal anomaly. Of 829 singleton SIA cases with normal karyotype, 221 (26.7%) were associated with other structural anomalies. Considering cases with normal karyotype, the total prevalence per 10 000 births was 1.6 (95% CI 1.5 to 1.7) for SIA, 0.9 (95% CI 0.8 to 1.0) for duodenal atresia and 0.7 (95% CI 0.7 to 0.8) for jejunoileal atresia (JIA). There was no significant trend in SIA, duodenal atresia or JIA prevalence over time (RR=1.0, 95% credible interval (CrI): 1.0 to 1.0 for each), but SIA and duodenal atresia prevalence varied by geographical location (p=0.03 and p=0.04, respectively). There was weak evidence of an increased risk of SIA in mothers aged less than 20 years compared with mothers aged 20 to 29 years (RR=1.3, 95% CrI: 1.0 to 1.8).</p></sec><sec><st>Conclusion</st><p>This study found no evidence of a temporal trend in the prevalence of SIA, duodenal atresia or JIA, although SIA and duodenal atresia prevalence varied significantly between registers.</p></sec>]]></description>
<dc:creator><![CDATA[Best, K. E., Tennant, P. W. G., Addor, M.-C., Bianchi, F., Boyd, P., Calzolari, E., Dias, C. M., Doray, B., Draper, E., Garne, E., Gatt, M., Greenlees, R., Haeusler, M., Khoshnood, B., McDonnell, B., Mullaney, C., Nelen, V., Randrianaivo, H., Rissmann, A., Salvador, J., Tucker, D., Wellesly, D., Rankin, J.]]></dc:creator>
<dc:date>2012-02-01T03:24:32-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300631</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300631</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Small intestine, Stomach and duodenum, Pregnancy, Reproductive medicine]]></dc:subject>
<dc:title><![CDATA[Epidemiology of small intestinal atresia in Europe: a register-based study]]></dc:title>
<prism:publicationDate>2012-02-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300752v1?rss=1">
<title><![CDATA[Risk factors for early sudden deaths and severe apparent life-threatening events]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300752v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To identify potential risk factors for unexpected sudden infant deaths (SID) and severe apparent life-threatening events (S-ALTE) within 24 h of birth.</p></sec><sec><st>Design</st><p>Case-control study embedded in an epidemiological survey over a 2-year period.</p></sec><sec><st>Patients and methods</st><p>Throughout 2009, every paediatric department in Germany was asked to report cases of unexplained SID or S-ALTE in term infants with a 10-min Apgar score &ge;8 to the Surveillance Unit for Rare Pediatric Conditions. Throughout 2010, the inclusion criteria were extended to infants &ge;35 week gestational age and those where an explanation for the deterioration had been found. For each unexplained case, hospitals were asked to fill in a questionnaire for 3 (near-)term controls with good postnatal adaptation at the age (in minutes) when the event had occurred in the case under study.</p></sec><sec><st>Results</st><p>Of the 85 cases reported, 34 fulfilled the entry criteria; of these, two were near-term newborns and, in three cases, a cause had been identified for the event. For the 31 cases with unknown cause for the event (13 males; mean (SD) gestational age 38.9 (1.7) week), the authors gathered 93 controls (51 male infants; 38.9 (1.4) week). As significant risk factors for S-ALTE and SID, the authors could identify primipara (OR 6.22; 95% CI 2.11 to 18.32) and potentially asphyxiating position (OR 6.45; 95% CI 1.22 to 34.10).</p></sec><sec><st>Conclusions</st><p>Close observation of newborns seems necessary, particularly in primipara; a potentially asphyxiating position should be avoided.</p></sec>]]></description>
<dc:creator><![CDATA[Poets, A., Urschitz, M. S., Steinfeldt, R., Poets, C. F.]]></dc:creator>
<dc:date>2012-01-31T04:30:20-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300752</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300752</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Child health, Infant health, SIDS]]></dc:subject>
<dc:title><![CDATA[Risk factors for early sudden deaths and severe apparent life-threatening events]]></dc:title>
<prism:publicationDate>2012-01-31</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300763v1?rss=1">
<title><![CDATA[Thrombocytopaenia and intraventricular haemorrhage in very premature infants: a tale of two cities]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300763v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To study whether the incidence of intraventricular haemorrhage (IVH) in very premature infants (&lt;32 weeks gestation) with thrombocytopaenia is lower when using a liberal platelet-transfusion guideline compared with a restrictive guideline.</p></sec><sec><st>Study design</st><p>A retrospective cohort study comparing the incidence of IVH in very premature infants with thrombocytopaenia (platelet count &lt;150<FONT FACE="arial,helvetica">x</FONT>10<sup>9</sup>/l) admitted between 2007 and 2008 to two neonatal intensive care unit in The Netherlands. The restrictive platelet-transfusion unit (N=353 infants &lt;32 weeks gestation) transfused only in case of active haemorrhage and a platelet count &lt;50<FONT FACE="arial,helvetica">x</FONT>10<sup>9</sup>/l. The liberal-transfusion unit (N=326 infants &lt;32 weeks gestation) transfused according to predefined platelet count thresholds. Primary outcome was the incidence and severity of IVH in infants with thrombocytopaenia in both units.</p></sec><sec><st>Results</st><p>The number of infants with thrombocytopaenia that received a platelet transfusion was significantly lower in the restrictive-transfusion unit compared with the liberal-transfusion unit, 15% (21/145) versus 31% (41/141), (p&lt;0.001). The incidence of IVH in infants with thrombocytopaenia in the restrictive-transfusion and liberal-transfusion units was 30% (44/145) and 29% (41/141), respectively (p=0.81). The incidence of severe IVH (grade 3 or 4) in the restrictive-transfusion and liberal-transfusion units was 8% (12/145) and 11% (16/141), respectively (p=0.38).</p></sec><sec><st>Conclusion</st><p>In the restrictive-transfusion unit, the rate of platelet transfusions was significantly lower, but the incidence and severity of IVH was similar to the liberal-transfusion unit.</p></sec>]]></description>
<dc:creator><![CDATA[von Lindern, J. S., Hulzebos, C. V., Bos, A. F., Brand, A., Walther, F. J., Lopriore, E.]]></dc:creator>
<dc:date>2012-01-31T03:43:05-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300763</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300763</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Child health, Infant health, Neonatal and paediatric intensive care, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Thrombocytopaenia and intraventricular haemorrhage in very premature infants: a tale of two cities]]></dc:title>
<prism:publicationDate>2012-01-31</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300578v1?rss=1">
<title><![CDATA[C reactive protein: impact on peripheral tissue oxygenation and perfusion in neonates]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300578v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>C reactive protein (CRP) is a sensitive marker of acute inflammation of infectious and non-infectious origin. Aim was to use near-infrared spectroscopy (NIRS) to analyse peripheral oxygenation and perfusion in term and preterm neonates with elevated CRP levels, at a time when routine haemodynamic variables are still normal.</p></sec><sec><st>Design</st><p>Prospective observational study.</p></sec><sec><st>Settings</st><p>Peripheral-muscle NIRS was performed in the first week of life. Tissue-oxygenation index (TOI), mixed venous oxygenation (SvO<SUB>2</SUB>), fractional oxygen extraction (FOE), haemoglobin flow (Hbflow), oxygen delivery (DO<SUB>2</SUB>) and oxygen consumption (VO<SUB>2</SUB>) were assessed. Blood samples were taken within 3 h of the NIRS measurements.</p></sec><sec><st>Patients</st><p>Cardiocirculatory stable term and preterm neonates with infection-related and infection-unrelated CRP elevations &gt;10 mg/l were compared with neonates without CRP elevation. The two groups were matched for gestational and postnatal age.</p></sec><sec><st>Results</st><p>33 neonates with CRP elevation (gestational age 37.7&plusmn;2.9 weeks) were compared with 33 controls (gestational age 37.3&plusmn;2.9 weeks). In neonates with CRP elevation, TOI (68.9&plusmn;6.6%), SvO<SUB>2</SUB> (66.9&plusmn;7.3%) DO<SUB>2</SUB> (39.2&plusmn;16.1 &micro;mol/100ml/min) and VO<SUB>2</SUB> (10.9&plusmn;3.4 &micro;mol/100ml/min) were significantly lower compared with controls (TOI 72.9&plusmn;3.8%, SvO<SUB>2</SUB> 70.2&plusmn;4.7%, DO<SUB>2</SUB> 48.8&plusmn;18.4 &micro;mol/100ml/min, VO<SUB>2</SUB> 12.3&plusmn;3.8 &micro;mol/100ml/min). There was no significant difference in any other NIRS or routine haemodynamic parameter between the two groups.</p></sec><sec><st>Conclusion</st><p>Inflammatory processes with CRP elevation cause impaired peripheral oxygenation and perfusion in neonates even when routine haemodynamic variables are still normal. NIRS might offer a new non-invasive tool for the early recognition and diagnosis of infectious and non-infectious inflammatory processes.</p></sec>]]></description>
<dc:creator><![CDATA[Pichler, G., Pocivalnik, M., Riedl, R., Pichler-Stachl, E., Zotter, H., Muller, W., Urlesberger, B.]]></dc:creator>
<dc:date>2012-01-31T03:43:05-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300578</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300578</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Immunology (including allergy), Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[C reactive protein: impact on peripheral tissue oxygenation and perfusion in neonates]]></dc:title>
<prism:publicationDate>2012-01-31</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300969v1?rss=1">
<title><![CDATA[Study of the costs and morbidities of late-preterm birth]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300969v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To compare late-preterm infants (33&ndash;36 weeks) with term infants (&ge;37 weeks) on incidence of morbidities in the first 3 years of life and healthcare costs during the first 2 years of life and third year of life.</p></sec><sec><st>Methods</st><p>Administrative health records of live infants born between January 1, 1997, and December 31, 2000 with 3 years follow-up data (N=35733) were linked. First, diagnoses of morbidities were compared between late-preterm and term infants using Cox's proportional hazards models. Healthcare costs expressed as mean total costs and cost ratios, accrued following initial hospital discharge after birth, were also examined.</p></sec><sec><st>Results</st><p>The three most common reasons for hospitalisation in late-preterm and term infants were acute bronchitis, otitis media and pneumonia. The most frequent reasons for physician visits included acute upper respiratory infections, otitis media and bronchiolitis. The highest HR were detected for chronic bronchitis 1.64 (1.13&ndash;2.39), hearing loss 1.56 (1.14&ndash;2.15) and bacterial diseases 1.28 (1.09&ndash;1.49). The mean total cost for late-preterm infants during the first 2 years of life was $2568 CAD compared with $1285 CAD for term infants, cost ratio =1.99 (95% CI 1.90 to 2.09). In the third year of life, the cost ratio reduced to 1.46 (95% CI 1.39 to 1.54).</p></sec><sec><st>Conclusions</st><p>Late-preterm infants are at higher risk of specific morbidities compared with term infants. Their mean total costs fall from almost double that of term infants during the first 2 years of life, to just 46% greater in the third year of life.</p></sec>]]></description>
<dc:creator><![CDATA[Berard, A., Le Tiec, M., De Vera, M. A.]]></dc:creator>
<dc:date>2012-01-31T03:43:05-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300969</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300969</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Health policy, Epidemiologic studies, Bronchiolitis, Otitis, Pneumonia (infectious disease), TB and other respiratory infections, Child health, Infant health, Bronchitis, Pneumonia (respiratory medicine), Ear, nose and throat/otolaryngology, Health economics, Health service research]]></dc:subject>
<dc:title><![CDATA[Study of the costs and morbidities of late-preterm birth]]></dc:title>
<prism:publicationDate>2012-01-31</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301090v1?rss=1">
<title><![CDATA[Continuous non-invasive cardiac output measurements in the neonate by electrical velocimetry: a comparison with echocardiography]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301090v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>Electrical velocimetry (EV) is a non-invasive method of continuous left cardiac output monitoring based on measurement of thoracic electrical bioimpedance. The objective was to validate EV by investigating the agreement in cardiac output measurements performed by EV and echocardiography.</p></sec><sec><st>Design</st><p>In this prospective observational study, left ventricular output (LVO) was simultaneously measured by EV (LVO<SUB>ev</SUB>) using Aesculon and by echocardiography (LVO<SUB>echo</SUB>) in healthy term neonates during the first 2 postnatal days. To determine the agreement between the two methods, we calculated the bias (mean difference) and precision (1.96<FONT FACE="arial,helvetica">x</FONT>SD of the difference). As LVO<SUB>echo</SUB> has its own limitations, the authors also calculated the &lsquo;true precision&rsquo; of EV adjusted for echocardiography as the reference method.</p></sec><sec><st>Results</st><p>The authors performed 115 paired measurements in 20 neonates. LVO<SUB>ev</SUB> and LVO<SUB>echo</SUB> were similar (534&plusmn;105 vs 538&plusmn;105 ml/min, p=0.7). The bias and precision of EV were &ndash;4 and 234 ml/min, respectively. The authors found the true precision of EV to be similar to the precision of echocardiography (31.6% vs 30%, respectively). There was no difference in bias and precision between the measurements obtained in patients with or without a haemodynamically significant patent ductus arteriosus.</p></sec><sec><st>Conclusions</st><p>EV is as accurate in measuring LVO as echocardiography and the variation in the agreement between EV and echocardiography among the individual subjects reflects the limitations of both techniques.</p></sec>]]></description>
<dc:creator><![CDATA[Noori, S., Drabu, B., Soleymani, S., Seri, I.]]></dc:creator>
<dc:date>2012-01-31T03:43:05-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301090</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301090</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Congenital heart disease, Echocardiography, Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[Continuous non-invasive cardiac output measurements in the neonate by electrical velocimetry: a comparison with echocardiography]]></dc:title>
<prism:publicationDate>2012-01-31</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300716v2?rss=1">
<title><![CDATA[Cooling and seizure burden in term neonates: an observational study]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300716v2?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To investigate any possible effect of cooling on seizure burden, the authors quantified the recorded electrographic seizure burden based on multichannel video-EEG recordings in term neonates with hypoxic-ischaemic encephalopathy (HIE) who received cooling and in those who did not.</p></sec><sec><st>Study design</st><p>Retrospective observational study.</p></sec><sec><st>Patients</st><p>Neonates &gt;37 weeks gestation born between 2003 and 2010 in two hospitals.</p></sec><sec><st>Methods</st><p>Off-line analysis of prolonged continuous multichannel video-EEG recordings was performed independently by two experienced encephalographers. Comparison between the recorded electrographic seizure burden in non-cooled and cooled neonates was assessed. Data were treated as non-parametric and expressed as medians with interquartile ranges (IQR).</p></sec><sec><st>Results</st><p>One hundred and seven neonates with HIE underwent prolonged continuous multichannel EEG monitoring. Thirty-seven neonates had electrographic seizures, of whom 31 had EEG recordings that were suitable for the analysis (16 non-cooled and 15 cooled). Compared with non-cooled neonates, multichannel EEG monitoring commenced at an earlier postnatal age in cooled neonates (6 (3&ndash;9) vs 15 (5&ndash;20) h)and continued for longer (88 (75&ndash;101) vs 55 (41&ndash;60) h). Despite this increased opportunity to capture seizures in cooled neonates, the recorded electrographic seizure burden in the cooled group was significantly lower than in the non-cooled group (60 (39&ndash;224) vs 203 (141&ndash;406) min). Further exploratory analysis showed that the recorded electrographic seizure burden was only significantly reduced in cooled neonates with moderate HIE (49 (26&ndash;89) vs 162 (97&ndash;262) min).</p></sec><sec><st>Conclusions</st><p>A decreased seizure burden was seen in neonates with moderate HIE who received cooling. This finding may explain some of the therapeutic benefits of cooling seen in term neonates with moderate HIE.</p></sec>]]></description>
<dc:creator><![CDATA[Low, E., Boylan, G. B., Mathieson, S. R., Murray, D. M., Korotchikova, I., Stevenson, N. J., Livingstone, V., Rennie, J. M.]]></dc:creator>
<dc:date>2012-01-23T01:07:31-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300716</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300716</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epilepsy and seizures, Child health]]></dc:subject>
<dc:title><![CDATA[Cooling and seizure burden in term neonates: an observational study]]></dc:title>
<prism:publicationDate>2012-01-23</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300244v1?rss=1">
<title><![CDATA[Outcomes at 7 years for babies who developed neonatal necrotising enterocolitis: the ORACLE Children Study]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300244v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>Within the ORACLE Children Study Cohort, the authors have evaluated long-term consequences of the diagnosis of confirmed or suspected neonatal necrotising enterocolitis (NEC) at age of 7 years.</p></sec><sec><st>Methods</st><p>Outcomes were assessed using a parental questionnaire, including the Health Utilities Index (HUI-3) to assess functional impairment, and specific medical and behavioural outcomes. Educational outcomes for children in England were explored using national standardised tests. Multiple logistic regression was used to explore independent associates of NEC within the cohort.</p></sec><sec><st>Results</st><p>The authors obtained data for 119 (77%) of 157 children following proven or suspected NEC and compared their outcomes with those of the remaining 6496 children. NEC was associated with an increase in risk of neonatal death (OR 14.6 (95% CI 10.4 to 20.6)).</p><p>At 7 years, NEC conferred an increased risk of all grades of impairment. Adjusting for confounders, risks persisted for any HUI-3 defined functional impairment (adjusted OR 1.55 (1.05, 2.29)), particularly mild impairment (adjusted OR 1.61 (1.03, 2.53)) both in all NEC children and in those with proven NEC, which appeared to be independent. No behavioural or educational associations were confirmed. Following NEC, children were more likely to suffer bowel problems than non-NEC children (adjusted OR 3.96 (2.06, 7.61)).</p></sec><sec><st>Conclusions</st><p>The ORACLE Children Study provided opportunity for the largest evaluation of school age outcome following neonatal NEC and demonstrates significant long-term consequences of both gut function (presence of stoma, admission for bowel problems and continuing medical care for gut-related problems) and motor, sensory and cognitive outcomes as measured using HUI-3.</p></sec>]]></description>
<dc:creator><![CDATA[Pike, K., Brocklehurst, P., Jones, D., Kenyon, S., Salt, A., Taylor, D., Marlow, N.]]></dc:creator>
<dc:date>2012-01-20T23:39:10-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300244</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300244</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Outcomes at 7 years for babies who developed neonatal necrotising enterocolitis: the ORACLE Children Study]]></dc:title>
<prism:publicationDate>2012-01-20</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301388v1?rss=1">
<title><![CDATA[The stoma that appeared from nowhere]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301388v1?rss=1</link>
<description><![CDATA[<p>A term baby with normal antenatal scans was postnatally diagnosed as having oesophageal atresia (OA) with tracheoesophageal fistula and an imperforate anus. The child had an umbilical venous catheter inserted, which was removed prior to surgery on day 2 of life. The OA was repaired and a divided colostomy was created. On day 8 postop, the nurse caring for the child enquired &lsquo;How do we look after the third stoma?&rsquo; (The nurse noted a third stoma at the umbilicus.) On examination, there was a protrusion from the umbilicus that resembled a perfectly formed stoma. No discharge was noted. A 6 Fr feeding tube inserted into this stoma revealed intestinal contents demonstrating that this was a patent vitello-intestinal duct. This stoma is currently under observation and it will be excised at the time of future laparotomy.</p><p>During the development of the midgut, a primary intestinal loop is formed as a result of...]]></description>
<dc:creator><![CDATA[Kuti, K., Paul, A., Desai, A.]]></dc:creator>
<dc:date>2012-01-20T23:39:10-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301388</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301388</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Journalology, Oesophagus, Reproductive medicine, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[The stoma that appeared from nowhere]]></dc:title>
<prism:publicationDate>2012-01-20</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300907v1?rss=1">
<title><![CDATA[Purpura fulminans in an acute preterm neonate]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300907v1?rss=1</link>
<description><![CDATA[<p>A baby was delivered by ventouse assistance at 35+6 weeks gestation following prolonged rupture of membranes and fetal distress in the second stage of labour. He was started on intravenous cefotaxime but at 13 h of age deteriorated with signs of septic shock and respiratory distress. He was admitted to the neonatal intensive care unit for resuscitation and ventilation. Blood cultures taken at 3 h of age confirmed a gram-negative septicaemia (fully sensitive <I>Escherichia coli</I>). Examination of the skin on day 2 revealed patchy purpura (initially on the neck, lip, sacrum and scrotum) and a right parietal cephalohaematoma. Cutaneous necrosis ensued in a number of these lesions, most marked on the posterior occiput (<cross-ref type="fig" refid="F1">figure 1</cross-ref>).</p><p>All skin lesions were managed conservatively with daily dressing changes, gel cushioning and 4 hourly position changes to relieve pressure. Gentle debridement was carried out at intervals under analgesia and with burns specialist nurse...]]></description>
<dc:creator><![CDATA[Church, J., Haram, N. H., Jones, I., Hartnoll, G.]]></dc:creator>
<dc:date>2012-01-20T00:12:49-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300907</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300907</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Journalology, Immunology (including allergy), Drugs: infectious diseases, Pain (neurology), Hypertension, Pregnancy, Pain (palliative care), Competing interests (ethics), Resuscitation, Trauma]]></dc:subject>
<dc:title><![CDATA[Purpura fulminans in an acute preterm neonate]]></dc:title>
<prism:publicationDate>2012-01-20</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301507v1?rss=1">
<title><![CDATA[Full term; an artificial concept]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301507v1?rss=1</link>
<description><![CDATA[<p>Babies born between 37 and 42 weeks of gestation are considered to have been born at the optimal time, and earlier or later delivery is known to be associated with increased risk of a range of outcomes from neonatal complications to impaired outcomes in terms of physical and intellectual ability and even death. Originally, there was an uncertainty about the length of gestation, because the basis for calculating gestational age (from the first day of the last menstrual period) was acknowledged as inaccurate due to conception at different points during the menstrual cycle and variation in an individual woman's cycle, thus a wide definition of full term was developed. With demand-led timing of delivery increasing around the world, many more babies are therefore delivered electively at 37&ndash;38 completed weeks of gestation, despite guidance from a range of official bodies.<cross-ref type="bib" refid="R1">1</cross-ref></p><p>This rather artificial concept is further cemented in place with...]]></description>
<dc:creator><![CDATA[Marlow, N.]]></dc:creator>
<dc:date>2012-01-19T00:40:00-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301507</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301507</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Pregnancy, Reproductive medicine, Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[Full term; an artificial concept]]></dc:title>
<prism:publicationDate>2012-01-19</prism:publicationDate>
<prism:section>Editorials</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301200v1?rss=1">
<title><![CDATA[Term neonates receiving intensive care at high risk of brainstem auditory impairment]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301200v1?rss=1</link>
<description><![CDATA[<p>Functional integrity of the auditory brainstem was examined using maximum length sequence brainstem auditory evoked response in 72 term neonates who were receiving intensive care. Compared with normal term controls, the neonates receiving intensive care showed an increase in wave V latency and I to V and III to V interpeak intervals of the response. Wave V latency was significantly increased at very high click rates 455 and 910/s. I to V and III to V intervals were significantly increased at all 91 to 910/s, particularly 455 and 910/s, while I to III intervals were slightly increased. III to V/I to III interval ratios were increased at 455 and 910/s clicks. The slopes of wave V latency-rate, I to V interval-rate, III to V interval-rate and III to V/I to III-interval-ratio-rate functions were significantly steeper than in normal controls. These abnormalities suggest that neonates receiving intensive care are at high risk of brainstem, mainly more central regions, auditory impairment. The MLS BAER abnormalities and brainstem auditory impairment might be the result of collective adverse effects, produced by more than one perinatal risk factor.</p>]]></description>
<dc:creator><![CDATA[Jiang, Z., Brosi, D., Yin, R., Wilkinsin, A. R.]]></dc:creator>
<dc:date>2012-01-19T00:40:00-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301200</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301200</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Neonatal and paediatric intensive care, Neonatal health, Disability]]></dc:subject>
<dc:title><![CDATA[Term neonates receiving intensive care at high risk of brainstem auditory impairment]]></dc:title>
<prism:publicationDate>2012-01-19</prism:publicationDate>
<prism:section>Short research reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301235v1?rss=1">
<title><![CDATA[Congenital right-sided para-umbilical abdominal wall hernia]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301235v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Case report</st><p>A 34-week gestation baby was born to a 45-year-old opiate dependent mother with limited prenatal care. Examination demonstrated a large skin-covered, right-sided para-umbilical mass, measuring 12<FONT FACE="arial,helvetica">x</FONT>14 cm, increasing in size with cry (<cross-ref type="fig" refid="F1">figure 1</cross-ref>). Umbilical ring was well formed and present around left base of the defect. On palpation, margins of the defect were smooth and intestines were reducible.</p><p>Abdominal film and upper gastrointestinal series showed a right-sided abdominal mass filled with loops of bowel. Sonographic evaluation revealed lack of abdominal wall muscles overlying the defect, whereas the peritoneal sac, other intra-abdominal organs, heart and intracranial structures were normal.</p><p>Surgical exploration revealed a hernial sac measuring 4<FONT FACE="arial,helvetica">x</FONT>4 cm with a substantial rim of surrounding fascia. There was no evidence of liver herniation or abnormality in its attachment. Bowel malrotation was evident and Ladd's procedure was performed. Fascial defect was approximated without any tension and was closed primarily in...]]></description>
<dc:creator><![CDATA[Ku, L., Kalra, V. K., Salinas, S., Chouthai, N., Pappas, A., Langenburg, S. E.]]></dc:creator>
<dc:date>2012-01-17T04:10:23-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301235</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301235</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Reproductive medicine, Neonatal and paediatric intensive care, Neonatal intensive care, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Congenital right-sided para-umbilical abdominal wall hernia]]></dc:title>
<prism:publicationDate>2012-01-17</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301464v1?rss=1">
<title><![CDATA[Trends in the incidence of retinopathy of prematurity in Lothian, south-east Scotland, from 1990 to 2009]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301464v1?rss=1</link>
<description><![CDATA[<p>Retinopathy of prematurity (ROP) is a disorder of retinal vascular development in premature infants and is a major cause of childhood blindness worldwide. Dhaliwal <I>et al</I> conducted a prospective, population-based study looking at the incidence of ROP in the Lothian region of south-east Scotland from 1990 to 2004 and found the following<cross-ref type="bib" refid="R1">1</cross-ref>:<l type="tab"><li><p>(1) Significant increase in survival of infants with birth weight &lt;1500 g and/or gestational age &lt;32 weeks</p></li><li><p>(2) Significant reduction in the number of infants treated for ROP</p></li><li><p>(3) Reduction in the incidence of any degree of ROP and severe (stage 3 or greater) ROP although both did not reach statistical significance.</p></li></l></p><p>Treatment criteria for ROP have changed in Lothian since the publication of the Early Treatment for Retinopathy of Prematurity (ETROP) study.<cross-ref type="bib" refid="R2">2</cross-ref> Before January 2005, infants with &lsquo;threshold&rsquo; or &lsquo;plus&rsquo; disease were treated. After January 2005, &lsquo;type 1&rsquo; ROP as defined by ETROP, stage 2 or...]]></description>
<dc:creator><![CDATA[Tan, S. Z., Dhaliwal, C., Becher, J.-C., Fleck, B.]]></dc:creator>
<dc:date>2012-01-12T20:21:47-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301464</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301464</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Trends in the incidence of retinopathy of prematurity in Lothian, south-east Scotland, from 1990 to 2009]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>PostScript</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301209v1?rss=1">
<title><![CDATA[Fetiform sacrococcygeal teratoma]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301209v1?rss=1</link>
<description><![CDATA[<p>Sacrococcygeal tumours (SCT's) are the common tumours of the neonatal age group; occasionally the appearance may mimic a sacral parasitic conjoined twin (SPCT). It is important to differentiate between the two as the former carries malignant potential and needs rigorous follow-up. This report highlights the differentiating features between the two entities.</p><p>A neonate was presented to us with a sacral mass of fetiform appearance (<cross-ref type="fig" refid="F1">figure 1A</cross-ref>). The radiological (<cross-ref type="fig" refid="F1">figure 1B</cross-ref>) and biochemical tests were unable to differentiate between SCT and SPCT. The mass was excised completely; histopathological examination confirmed the diagnosis of mature SCT. The differential diagnosis in our case was a SPCT. This is a rare anomaly with an incomplete twin (parasite) attached to the sacrococcygeal region of the co-twin (autosite). The differentiation between these two is important as SCT's carry malignant potential.<cross-ref type="bib" refid="R1">1</cross-ref> <cross-ref type="bib" refid="R2">2</cross-ref></p><p>A parasitic twin can have recognisable body parts such...]]></description>
<dc:creator><![CDATA[Kattepura, S., Sahadev, R., Munianjanappa, N., Shankar, G., Santhanakrishnan, R.]]></dc:creator>
<dc:date>2012-01-12T23:53:28-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301209</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301209</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Journalology, Reproductive medicine, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Fetiform sacrococcygeal teratoma]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300412v1?rss=1">
<title><![CDATA[Geographical disparities of infant mortality in rural China]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300412v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>The purpose of the study was to investigate the trends and causes of regional disparities of infant mortality rate (IMR) in rural China from 1996 to 2008.</p></sec><sec><st>Design</st><p>A population-based, longitudinal study.</p></sec><sec><st>Setting</st><p>The national child mortality surveillance network.</p></sec><sec><st>Population</st><p>Population of the 79 surveillance counties.</p></sec><sec><st>Main outcome measure</st><p>IMR, leading causes of infant death and the RR of IMR.</p></sec><sec><st>Results</st><p>The IMR in coastal, inland and remote regions declined by 72.4%, 62.9% and 58.2%, respectively, from 1996 to 2008. Compared with the coastal region, the RR of IMR were 1.7 (95% CI 1.6 to 1.9), 1.9 (95% CI 1.7 to 2.0) and 1.8 (95% CI 1.6 to 2.0) for inland region and 2.6 (95% CI 2.4 to 2.7), 3.2 (95% CI 3.0 to 3.5) and 3.1 (95% CI 2.7 to 3.4) for the remote region during 1996&ndash;2000, 2001&ndash;2005 and 2006&ndash;2008, respectively. The regional disparities existed for both male and female IMRs. The postneonatal mortality showed the highest regional disparities. Pneumonia, birth asphyxia, prematurity/low birth weight, injuries and diarrhoea were the main contributors to the regional disparities. There were significantly more infants who did not seek healthcare services before death in the remote region relative to the inland and coastal regions.</p></sec><sec><st>Conclusion</st><p>The results indicated persistent existence of regional disparities in IMR in rural China. It is worth noting that regional disparities in IMR increased in the remote and coastal regions during 2001&ndash;2005 in rural China. These disparities remained unchanged during 2006&ndash;2008. The results indicate that strategies to reduce mortality caused by pneumonia, birth asphyxia and diarrhoea are keys to reducing IMR.</p></sec>]]></description>
<dc:creator><![CDATA[Wang, Y., Zhu, J., He, C., Li, X., Miao, L., Liang, J.]]></dc:creator>
<dc:date>2012-01-12T23:53:28-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300412</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300412</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Diarrhoea, Epidemiologic studies, Unlocked, Pneumonia (infectious disease), TB and other respiratory infections, Child health, Pneumonia (respiratory medicine), Trauma, Injury]]></dc:subject>
<dc:title><![CDATA[Geographical disparities of infant mortality in rural China]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300405v1?rss=1">
<title><![CDATA[Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300405v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To study risk factors and cranial ultrasound (cUS) findings in a large cohort of preterm infants, admitted to a neonatal intensive care unit and diagnosed with postnatally acquired cytomegalovirus (CMV) infection.</p></sec><sec><st>Study design</st><p>This prospective, observational study was performed from April 2007 until June 2009 among 315 infants born &lt;32 weeks of gestation. Postnatal CMV infection was diagnosed by CMV PCR on urine collected at term-equivalent age. In CMV-positive infants, congenital infection was excluded. The authors compared the clinical and demographic data, feeding pattern and cUS results of infected and non-infected patients. Logistic regression analysis was performed.</p></sec><sec><st>Results</st><p>In 39 of 315 infants, the diagnosis of postnatal CMV infection has been made. The majority of CMV-infected infants (33/39.85%) did not develop any symptoms of CMV infection. The most important, independent risk factors of postnatal CMV infection were non-native Dutch maternal origin (OR 9.6 (95% CI 4.3 to 21.5)) and breast milk (OR 13.2 (95% CI 1.7 to 104.5)). The risk of infection significantly increased in infants with lower gestational age (GA) (OR 0.7 (95% CI 0.5 to 0.9)). Lenticulostriate vasculopathy (LSV) was significantly more often present in infants with CMV infection (OR 4.1 (95% CI 1.9 to 8.8)).</p></sec><sec><st>Conclusions</st><p>Postnatal CMV infection is an asymptomatic infection among preterm infants. Infants with lower GA are at greatest risk of postnatal CMV infection, especially when fed with fresh breast milk from their non-native Dutch mother. LSV not present at birth but confirmed at term-equivalent age can suggest a postnatal CMV infection.</p></sec>]]></description>
<dc:creator><![CDATA[Nijman, J., de Vries, L. S., Koopman-Esseboom, C., Uiterwaal, C. S. P. M., van Loon, A. M., Verboon-Maciolek, M. A.]]></dc:creator>
<dc:date>2012-01-12T23:53:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300405</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300405</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Childhood nutrition, Reproductive medicine, Child health, Infant health, Infant nutrition (including breastfeeding), Neonatal health, Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301008v1?rss=1">
<title><![CDATA[Trends and centre-to-centre variability in survival rates of very preterm infants (<32 weeks) over a 10-year-period in Switzerland]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301008v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>The publication of Swiss guidelines for the care of infants at the limit of viability (22&ndash;25 completed weeks) was followed by increased survival rates in the more mature infants (25 completed weeks). At the same time, considerable centre-to-centre (CTC) differences were noted.</p></sec><sec><st>Objectives</st><p>To examine the trend of survival rates of borderline viable infants over a 10-year-period and to further explore CTC differences.</p></sec><sec><st>Design</st><p>Population-based, retrospective cohort study.</p></sec><sec><st>Setting</st><p>All nine level III neonatal intensive care units (NICUs) and affiliated paediatric hospitals in Switzerland.</p></sec><sec><st>Patients</st><p>6532 preterm infants with a gestational age (GA) &lt;32 weeks born alive between 1 January 2000 and 31 December 2009.</p></sec><sec><st>Main outcome measures</st><p>Trends of GA-specific delivery room and NICU mortality rates and survival rates to hospital discharge were assessed. For CTC comparisons, centre-specific risk-adjusted ORs for survival were calculated in three GA groups: A: 23 0/7 to 25 6/7 weeks (n=976), B: 26 0/7 to 28 6/7 weeks (n=1943) and C: 29 0/7 to 31 6/7 weeks (n=3399).</p></sec><sec><st>Results</st><p>Survival rates of infants with a GA of 25 completed weeks which had improved from 42% in 2000/2001 to 60% in 2003/2004 remained unchanged at 63% over the next 5 years (2005&ndash;2009). Statistically significant CTC differences have persisted and are not restricted to borderline viable infants.</p></sec><sec><st>Conclusions</st><p>In Switzerland, survival rates of infants born at the limit of viability have remained unchanged over the second half of the current decade. Risk-adjusted CTC outcome variability cannot be explained by differences in baseline demographics or centre case loads.</p></sec>]]></description>
<dc:creator><![CDATA[Berger, T. M., Steurer, M. A., Woerner, A., Meyer-Schiffer, P., Adams, M., for the Swiss Neonatal Network]]></dc:creator>
<dc:date>2012-01-12T23:53:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301008</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301008</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Unlocked, Child health, Infant health, Neonatal and paediatric intensive care, Neonatal health, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[Trends and centre-to-centre variability in survival rates of very preterm infants (<32 weeks) over a 10-year-period in Switzerland]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301016v1?rss=1">
<title><![CDATA[Postnatally diagnosed neonatal lupus]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301016v1?rss=1</link>
<description><![CDATA[<p>A baby was delivered by elective caesarean section at 34 weeks' gestation because of decreased intrauterine growth velocity to a non-consanguineous Chinese couple. He was found to have a widespread atrophic and ulcerative rash over his face and upper body (<cross-ref type="fig" refid="F1">figure 1</cross-ref>). Deep purple papules were noted on his feet, which resolved over days. He also developed profound thrombocytopenia requiring platelet transfusion and later developed pancytopenia. Microbiological and serological investigations (Toxoplasmosis, Rubella, Cytomegalovirus, herpes) were all negative. His mother became coagulopathic requiring product support immediately postpartum.</p><p>Skin biopsy suggested neonatal lupus, which was confirmed serologically. His mother later presented with suspected postpartum sepsis, but in view of his diagnosis, the mother wasconfirmed to have systemic lupus erythematosus. She responded well to systemic corticosteroid therapy.</p><p>The deterioration in his rash reached a nadir at 3 months of age (<cross-ref type="fig" refid="F2">figure 2</cross-ref>), and subsequently self-resolved with the passage of maternal antibodies....]]></description>
<dc:creator><![CDATA[Holme, H., Mun, K. S.]]></dc:creator>
<dc:date>2012-01-12T23:53:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301016</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301016</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Surgery, Journalology, Immunology (including allergy), Pathology, Radiology, Rheumatology, Surgical diagnostic tests, Clinical diagnostic tests, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Postnatally diagnosed neonatal lupus]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301096v1?rss=1">
<title><![CDATA[Prevention of preterm births: are we looking in the wrong place? The case for primary prevention]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301096v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Introduction</st><p>Preterm birth is the major cause of neonatal and infant mortality in the developed world, being responsible for 55% and 43% of neonatal and infant deaths, respectively, in England and Wales.<cross-ref type="bib" refid="R1">1</cross-ref> With nearly 50 000 preterm births (before 37 weeks gestation) a year in England and Wales (7.6%), the burden is large and research has estimated the annual cost of these babies to be nearly &pound;3 billion<cross-ref type="bib" refid="R2">2</cross-ref> reflecting both initial care costs and ongoing morbidity.</p><p>To date, both the clinical response and the research agenda have concentrated on two main areas: (1) optimising neonatal care practices and interventions and (2) secondary preventive strategies after preterm birth is threatened or an underlying condition recognised. In terms of neonatal care, there have been major advances in the past 30 years particularly in infants of 32 weeks gestation or less; however, it is unlikely that further dramatic changes will...]]></description>
<dc:creator><![CDATA[Rattihalli, R., Smith, L., Field, D.]]></dc:creator>
<dc:date>2012-01-12T20:21:47-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301096</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301096</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Obstetrics and gynaecology, Smoking and tobacco, Epidemiologic studies, Drugs: infectious diseases, Drugs: cardiovascular system, Malnutrition, Obesity (nutrition), Contraception, Pregnancy, Reproductive medicine, Child health, Infant health, Neonatal health, Dentistry and oral medicine, Sexual health, Health education, Obesity (public health), Health promotion, Smoking]]></dc:subject>
<dc:title><![CDATA[Prevention of preterm births: are we looking in the wrong place? The case for primary prevention]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Leading articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300773v1?rss=1">
<title><![CDATA[Visible thyroid ectopia]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300773v1?rss=1</link>
<description><![CDATA[<p>A 29-day-old infant was referred by the newborn screening laboratory with mild but persistent capillary thyroid stimulating hormone (TSH) elevation: 11 mU/l on day 5 of life and 19.5 mU/l on day 23. He was born in the 39th week by planned caesarean section weighing 3814 g and was discharged home on day 3 without any health concerns. However, his mother had noticed a small lump on his neck which she took to be the baby's &lsquo;Adam&rsquo;s apple'.</p><p>Clinical examination was normal apart from a palpable lump in the upper neck located slightly to the right of the midline (<cross-ref type="fig" refid="F1">figure 1</cross-ref>). Neck ultrasound showed this to be an anvil-shaped, highly vascular homogenous structure measuring 0.9<FONT FACE="arial,helvetica">x</FONT>1.1<FONT FACE="arial,helvetica">x</FONT>1.3 cm, lying at and beneath the level of the base of the tongue (<cross-ref type="fig" refid="F2">figure 2</cross-ref>), and there was non-thyroidal tissue within the thyroid fossa.</p><p>Radioisotope scanning using 13 MBq pertechnetate showed uptake in...]]></description>
<dc:creator><![CDATA[Yeap, P. M., Attaie, M., Jones, J., Maroo, S., Donaldson, M.]]></dc:creator>
<dc:date>2012-01-12T20:21:47-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300773</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300773</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Drugs: CNS (not psychiatric), Radiology, Clinical diagnostic tests, Radiology (diagnostics), Screening (epidemiology), Competing interests (ethics), Thyroid disease, Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Visible thyroid ectopia]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300094v1?rss=1">
<title><![CDATA[Workload and costs associated with providing a neonatal surgery service]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300094v1?rss=1</link>
<description><![CDATA[<sec><st>Aim</st><p>To identify the workload related to provision of a neonatal surgical service in a UK neonatal network in order to inform local and national service commissioning.</p></sec><sec><st>Method</st><p>Data relating to neonatal surgical admissions to a level 3 perinatal centre serving a network with 36 000 births per year collected prospectively over a 5-year period were analysed to identify annual activity. Daily dependency was assessed prospectively over a 6-month period and service costs calculated using existing local tariffs. Admissions from outside the network were excluded from analysis, and allowance was made for refused network admissions.</p></sec><sec><st>Results</st><p>On average 140 admissions required 2137 cot-days per year. At 80% occupancy, the service requires seven neonatal cots suggesting that there is a national requirement for one neonatal surgical cot per 5000 births. Intensive care, high care (HC) and special care accounted for 37%, 46% and 17% of cot-days, respectively. This equates to an annual service cost of &pound;2m, about &pound;250 000 per 5000 births.</p></sec><sec><st>Conclusions</st><p>This assessment of the facilities and costs required to provide a neonatal surgical service in a level 3 perinatal centre in the UK may be used to inform network and national commissioning.</p></sec>]]></description>
<dc:creator><![CDATA[Burge, D. M., Drewett, M.]]></dc:creator>
<dc:date>2012-01-12T20:21:46-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300094</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300094</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Neonatal and paediatric intensive care, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Workload and costs associated with providing a neonatal surgery service]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300872v1?rss=1">
<title><![CDATA[National neonatal data to support specialist care and improve infant outcomes]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300872v1?rss=1</link>
<description><![CDATA[<p>&lsquo;Liberating the NHS&rsquo; and the new Outcomes Framework make information central to the management of the UK National Health Service (NHS). The principles of patient choice and government policy on the transparency of outcomes for public services are key drivers for improving the performance. Specialist neonatal care is able to respond positively to these challenges owing to the development of a well-defined dataset and comprehensive national data collection. When combined with analysis, audit and feedback at the national level, this is proving to be an effective means to harness the potential of clinical data. Other key characteristics have been an integrated approach to ensure that data are captured once and serve multiple needs, collaboration between professional organisations, parents, academic institutions, the commercial sector and NHS managers, and responsiveness to changing requirements. The authors discuss these aspects of national neonatal specialist data and point to future developments.</p>]]></description>
<dc:creator><![CDATA[Spencer, A., Modi, N.]]></dc:creator>
<dc:date>2012-01-03T07:12:17-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300872</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300872</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[National neonatal data to support specialist care and improve infant outcomes]]></dc:title>
<prism:publicationDate>2012-01-03</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300929v1?rss=1">
<title><![CDATA[Electrolytes in sick neonates - which sodium is the right answer?]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300929v1?rss=1</link>
<description><![CDATA[<sec><st>Introduction</st><p>Hypoproteinaemia leads to spuriously high-sodium values when measured by indirect ion-selective electrodes (ISE) as used in main laboratory analysers compared with direct ISE employed in point-of-care analysers (POCT). The authors, therefore, investigated the occurrence of hypoalbuminaemia and its effect on measured sodium from POCT and the main laboratory analyser of neonatal intensive-care samples.</p></sec><sec><st>Method</st><p>Sodium, in paired retrospective samples, measured by the main laboratory and neonatal unit blood-gas (POCT) analysers were compared.</p></sec><sec><st>Results</st><p>Hypoalbuminaemia (&lt;30 g/l) was present in 1400/2420 paired results. Sodium was higher when measured by laboratory analyser, the difference increased with decreasing albumin; sodium (laboratory &ndash; POCT)=7.6 (&plusmn;1.1)&ndash;0.22 (&plusmn;0.04)<FONT FACE="arial,helvetica">x</FONT>albumin. A difference &gt;3 mmol/l was present in 31% and consequently underestimated (9.4%) hyponatraemia and overestimated (3.8%) hypernatraemia.</p></sec><sec><st>Conclusion</st><p>Hypoalbuminaemia is common in sick neonates and monitoring electrolytes using POCT and laboratory analysers frequently yield significantly different results with consequent misclassification. In these patients, measurement of electrolytes by direct ISE (blood-gas analyser) may be more accurate.</p></sec>]]></description>
<dc:creator><![CDATA[King, R. I., Mackay, R. J., Florkowski, C. M., Lynn, A. M.]]></dc:creator>
<dc:date>2012-01-03T07:12:16-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300929</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300929</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Metabolic disorders]]></dc:subject>
<dc:title><![CDATA[Electrolytes in sick neonates - which sodium is the right answer?]]></dc:title>
<prism:publicationDate>2012-01-03</prism:publicationDate>
<prism:section>Short research reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300888v1?rss=1">
<title><![CDATA[Early term and late preterm birth are associated with poorer school performance at age 5 years: a cohort study]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300888v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To compare school performance at age 5 years in children born at full term (39&ndash;41 weeks gestation) with those born at early term (37&ndash;38 weeks gestation), late preterm (34&ndash;36 weeks gestation), moderately preterm (32&ndash;33 weeks gestation) and very preterm (&lt;32 weeks gestation).</p></sec><sec><st>Design</st><p>Population-based cohort (UK Millennium Cohort Study).</p></sec><sec><st>Participants</st><p>Seven thousand six hundred and fifty children born in 2000&ndash;2001 and attending school in England in 2006.</p></sec><sec><st>Methods</st><p>School performance was measured using the foundation stage profile (FSP), a statutory assessment by teachers at the end of the child's first school year. The FSP comprises 13 assessment scales (scored from 1 to 9). Children who achieve an average of 6 points per scale and at least 6 in certain scales are classified as &lsquo;reaching a good level of overall achievement&rsquo;.</p></sec><sec><st>Results</st><p>Fifty-one per cent of full term children had not reached a good level of overall achievement; this proportion increased with prematurity (55% in early term, 59% in late preterm, 63% in moderately preterm and 66% in very preterm children). Compared with full term children, an elevated risk remained after adjustment, even in early term (adjusted RR 1.05, 95% 1.00 to 1.11) and late preterm children (adjusted RR 1.12, 95% CI 1.04 to 1.22). Similar effects were noted for &lsquo;not working securely&rsquo; in mathematical development, physical development and creative development. The effects of late preterm and early term birth were small in comparison with other risk factors.</p></sec><sec><st>Conclusions</st><p>Late preterm and early term birth are associated with an increased risk of poorer educational achievement at age 5 years.</p></sec>]]></description>
<dc:creator><![CDATA[Quigley, M. A., Poulsen, G., Boyle, E., Wolke, D., Field, D., Alfirevic, Z., Kurinczuk, J. J.]]></dc:creator>
<dc:date>2012-01-03T07:12:16-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300888</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300888</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Pregnancy, Developmental paediatrics]]></dc:subject>
<dc:title><![CDATA[Early term and late preterm birth are associated with poorer school performance at age 5 years: a cohort study]]></dc:title>
<prism:publicationDate>2012-01-03</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301148v1?rss=1">
<title><![CDATA[Are we there yet? Bevacizumab therapy for retinopathy of prematurity]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301148v1?rss=1</link>
<description><![CDATA[<p>The publication of the BEAT-ROP study of bevacizumab (Avastin) treatment for Zone I and II retinopathy of prematurity (ROP) has raised hopes that there might now be a simpler, cheaper and more effective treatment than laser therapy, the current standard of care. However, we would urge caution at this point in time. We review the scientific background to the use of intravitreal anti-vascular endothelial growth factor for ROP, highlight a number of design issues in the BEAT-ROP study and problems with interpretation of the results. For example, no visual outcomes were reported and the study was underpowered to assess longer term safety. Intravitreal bevacizumab leaks into the systemic circulation in animals and adult humans and there are real concerns of potential harm to the developing preterm infant because vascular growth factors play a critical role in organogenesis. We conclude that bevacizumab should be reserved for exceptional circumstances and compassionate use pending further studies. Laser remains the proven effective therapy for first line treatment of all forms of ROP with little systemic morbidity. Neonatology and ophthalmology have an impressive record of conducting collaborative multicentre studies and we urgently need further rigorously designed, adequately powered randomised trials of anti-VEGF agents that evaluate visual outcomes as well as short and long term ocular and systemic safety.</p>]]></description>
<dc:creator><![CDATA[Darlow, B. A., Ells, A. L., Gilbert, C. E., Gole, G. A., Quinn, G. E.]]></dc:creator>
<dc:date>2011-12-30T01:47:56-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301148</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301148</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Are we there yet? Bevacizumab therapy for retinopathy of prematurity]]></dc:title>
<prism:publicationDate>2011-12-30</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301041v1?rss=1">
<title><![CDATA[Volume-targeted ventilation in infants born at or near term]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301041v1?rss=1</link>
<description><![CDATA[<sec><st>Objectives</st><p>To determine the impact of different volume-targeted (VT) levels during volume-targeted ventilation (VTV) on the work of breathing (WOB) of infants born at or near term and to investigate whether a level of VT reduced the WOB below that experienced on respiratory support without VT.</p></sec><sec><st>Design</st><p>Prospective crossover study.</p></sec><sec><st>Patients</st><p>Sixteen infants, median gestational age of 38 (range 34&ndash;41) weeks, birth weight of 3.1 (range 1.5&ndash;4.1) kg and postnatal age of 5 (range 2&ndash;17) days were studied. The infants were receiving time-cycled, pressure-limited ventilation in a continuous mandatory or in a triggered mode.</p></sec><sec><st>Interventions</st><p>The infants were studied first without VT (baseline) and then at VT levels of 4, 5 and 6 ml/kg delivered in a random order. After each VT level, the infants were returned to baseline.</p></sec><sec><st>Main outcome measure</st><p>The WOB was assessed by measuring the transdiaphragmatic pressure-time product (PTPdi).</p></sec><sec><st>Results</st><p>One infant became apnoeic at VT of 6 ml/kg. At a VT level of 4 ml/kg, four infants were making such vigorous respiratory efforts that no inflations were delivered. The median PTPdi was higher at a VT level of 4 ml/kg than at 5 ml/kg (p&lt;0.01) or 6 ml/kg (p&lt;0.001). Only at a VT level of 6 ml/kg was the median PTPdi lower than that at baseline (p&lt;0.01).</p></sec><sec><st>Conclusion</st><p>Low VT levels (4 ml/kg) during VTV increase the WOB in ventilated infants born at term or near term. The results suggest that a VT level of 6 ml/kg could be used to reduce the WOB.</p></sec>]]></description>
<dc:creator><![CDATA[Chowdhury, O., Rafferty, G. F., Lee, S., Hannam, S., Milner, A. D., Greenough, A.]]></dc:creator>
<dc:date>2011-12-22T02:02:02-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301041</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301041</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Airway biology]]></dc:subject>
<dc:title><![CDATA[Volume-targeted ventilation in infants born at or near term]]></dc:title>
<prism:publicationDate>2011-12-22</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301317v1?rss=1">
<title><![CDATA[First report of topical timolol treatment in primarily ulcerated perineal haemangioma]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301317v1?rss=1</link>
<description><![CDATA[<p>Ulceration, the most common complication of infantile haemangiomas (IH), occurs in about 16% of all IH. Moreover, diaper area, lower lip and neck are the usual risk factor localisations for this occurrence.<cross-ref type="bib" refid="R1">1</cross-ref> In 2008, L&eacute;aut&eacute;-Labr&egrave;ze <I>et al</I><cross-ref type="bib" refid="R2">2</cross-ref> serendipitously discovered the antiproliferative effect of &beta; blockers on IH. Since then, oral propranolol has become the first-line systemic treatment for complicated IHs, even when ulcerated.<cross-ref type="bib" refid="R3">3</cross-ref> Following, several publications have reported the use of topical &beta; blockers in non-complicated IH.<cross-ref type="bib" refid="R4">4</cross-ref> We herein report our personal experience of the use of timolol, a non-selective &beta; blocker, in two neonates with an unusual primarily ulcerated lesion of the perineum area. This study was approved by the institutional review board of our institution.</p><p>Case 1 is that of a 24-day-old newborn girl presenting with ulceration on the right buttock. She was born at 39 weeks' estimated gestational age. Birth...]]></description>
<dc:creator><![CDATA[Cante, V., Pham-Ledard, A., Imbert, E., Ezzedine, K., Leaute-Labreze, C.]]></dc:creator>
<dc:date>2011-12-21T01:17:32-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301317</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301317</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[First report of topical timolol treatment in primarily ulcerated perineal haemangioma]]></dc:title>
<prism:publicationDate>2011-12-21</prism:publicationDate>
<prism:section>PostScript</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301480v1?rss=1">
<title><![CDATA[Strategies to manage resistant gram-negative organisms in neonates]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301480v1?rss=1</link>
<description><![CDATA[<p>Gram-negative antibiotic resistance is currently of major concern worldwide. In the UK, the prevalence of multi-resistant gram-negative bacteria (MRGNB) is increasing,<cross-ref type="bib" refid="R1">1</cross-ref> and outbreaks have occurred in neonatal units (NNUs).</p><p>Up to 12% of neonates undergo a septic screen at birth, and most of them receive empiric antibiotics.<cross-ref type="bib" refid="R2">2</cross-ref> Around 70% of NNUs use narrow-spectrum penicillin/gentamicin combinations for empiric treatment of neonatal sepsis.<cross-ref type="bib" refid="R3">3</cross-ref> However, these regimens may not be active against MRGNB. Vergnano <I>et al</I><cross-ref type="bib" refid="R4">4</cross-ref> found that <I>Enterobacteriaceae</I> accounted for around 20% to 35% of early- and late-onset sepsis, respectively, underlining the threat that MRGNB pose in neonatology. Unlike many other antibiotic-resistant bacteria, MRGNB occur in the community as well as in hospitals, meaning that there is a growing risk of mother-to-baby transmission of MRGNB. This could lead to infected babies being inadequately treated with standard antibiotics, and asymptomatically colonised babies could act as a...]]></description>
<dc:creator><![CDATA[Wickramasinghe, N., Suviste, J., Patel, M., Gray, J.]]></dc:creator>
<dc:date>2011-12-21T01:17:32-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301480</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301480</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Strategies to manage resistant gram-negative organisms in neonates]]></dc:title>
<prism:publicationDate>2011-12-21</prism:publicationDate>
<prism:section>PostScript</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300117v1?rss=1">
<title><![CDATA[The first five inflations during resuscitation of prematurely born infants]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300117v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To study the first five inflations during the resuscitation of prematurely born infants and whether the infant's inspiratory efforts influenced the expired tidal volume.</p></sec><sec><st>Design</st><p>Prospective observational study.</p></sec><sec><st>Setting</st><p>Two tertiary perinatal centres.</p></sec><sec><st>Patients</st><p>Thirty infants, median gestational age 30 (23&ndash;34) weeks.</p></sec><sec><st>Interventions</st><p>The first five inflations delivered via a face mask and t-piece device were examined using respiratory function monitoring.</p></sec><sec><st>Main outcome measures</st><p>Inflation pressures, inflation times and expiratory volumes were recorded and comparison made of inflations during which the infant made an inspiratory effort (active inflation) or did not (passive inflation).</p></sec><sec><st>Results</st><p>Overall, the median expired tidal volume was 2.5 (0&ndash;19.8) ml/kg and was lower for passive (median 2.1 ml/kg, range 0&ndash;19.8 ml/kg) compared with active (median 5.6 ml/kg, range 1.2&ndash;12.2 ml/kg) inflations (ratio of geometric means 1.85, 95% CI 1.18 to 28%) (p=0.007). Overall, the median face mask leak was 54.5% and was lower for active (34.5%) compared with passive (60.7%) inflations (mean difference in % leak: 12.4%, 95% CI 0.9 to 24%) (p=0.0354). There was a significant positive correlation between the expiratory volumes and the inflation pressures (R2 between subjects 0.19, p=0.04) and a negative correlation between the expiratory tidal volumes and the face mask leaks (R2 between subjects=0.051, p&lt;0.001), but there was no significant correlation between the inflation times and the expiratory tidal volumes.</p></sec><sec><st>Conclusion</st><p>The expired tidal volume, inflation pressures and times during the first five inflations during resuscitation were variable. The expired tidal volumes were significantly greater if the infant inspired during the inflation.</p></sec>]]></description>
<dc:creator><![CDATA[Murthy, V., Dattani, N., Peacock, J. L., Fox, G. F., Campbell, M. E., Milner, A. D., Greenough, A.]]></dc:creator>
<dc:date>2011-12-15T00:31:08-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300117</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300117</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Airway biology, Resuscitation]]></dc:subject>
<dc:title><![CDATA[The first five inflations during resuscitation of prematurely born infants]]></dc:title>
<prism:publicationDate>2011-12-15</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300381v1?rss=1">
<title><![CDATA[Patent ductus arteriosus: to treat or not to treat?]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300381v1?rss=1</link>
<description><![CDATA[<p>Persistent patency of the ductus arteriosus in the preterm infant is associated with numerous morbidities, including higher rates of bronchopulmonary dysplasia and increased mortality. These strong associations have led to widespread use of cyclooxygenase inhibitors and surgical ligation to achieve ductal closure in the expectation that closing the ductus will reduce these complications. Each of these interventions has its own associated adverse effects. Neither individual randomised controlled trials nor meta-analyses of those trials have been able to demonstrate long-term benefits of these treatments despite their efficacy in inducing ductal closure and reducing the need for ductal ligation. Despite the potential shortcomings of those trials, they provide substantial cumulative evidence that early, routine treatment to close a persistently patent ductus arteriosus in preterm infants does not improve outcomes and should therefore be abandoned. Future trials of these interventions for patent ductus management should address different questions. Persistence of ductal patency should be considered a sign of rather than a direct cause of the several morbidities with which it is clearly associated. Practitioners should tolerate ductal patency and learn to manage its causes and consequences rather than focusing on achievement of ductal closure.</p>]]></description>
<dc:creator><![CDATA[Benitz, W. E.]]></dc:creator>
<dc:date>2011-12-15T00:31:08-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300381</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300381</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Bronchopulmonary dysplasia, Epidemiologic studies, Congenital heart disease, Child health, Infant health, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Patent ductus arteriosus: to treat or not to treat?]]></dc:title>
<prism:publicationDate>2011-12-15</prism:publicationDate>
<prism:section>Leading articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300822v1?rss=1">
<title><![CDATA[Segmental percutaneous central venous line cultures for diagnosis of catheter-related sepsis]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300822v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>Culture of percutaneous central venous line (PCVL) segments may assist the diagnosis of line colonisation and catheter-related sepsis (CRS). The authors aimed to determine if the diagnosis of CRS and colonisation of PCVLs in neonates is improved by the culture of the proximal and middle segments of the line in addition to the tip.</p></sec><sec><st>Patients and methods</st><p>In a prospective study, proximal, middle and tip segments of PCVLs indwelling for more than 24 h in term and preterm infants were sent for culture at line removal. Definite CRS was considered as a positive peripheral blood culture plus any line segment growing the same organism in an infant with clinical signs of sepsis.</p></sec><sec><st>Results</st><p>189 lines were removed from 143 neonates: 142 (75%) were from well infants and 47 (25%) were from neonates with suspected clinical sepsis. The overall CRS rate was 7.9% (15 of 189 line episodes). In well infants, bacterial colonisation rates were significantly higher for proximal segments than for tips (p=0.004). Comparative rates of segmental culture positivity and their positive predictive values for definite CRS were similar for all segments. The diagnosis of CRS was not improved beyond a sole line tip culture by additional middle or proximal segmental cultures or by combinations of the three segments.</p></sec><sec><st>Conclusion</st><p>In well infants, the proximal segments of PCVLs were more often colonised than line tips, but in clinically septic infants preferential culture of proximal or middle segments or combinations of the three segments did not permit better prediction of definite CRS than the culture of the line tip alone. Further studies prior to antibiotic therapy are indicated in babies with suspected CRS.</p></sec>]]></description>
<dc:creator><![CDATA[Ponnusamy, V., Venkatesh, V., Curley, A., Musonda, P., Brown, N., Tremlett, C., Clarke, P.]]></dc:creator>
<dc:date>2011-12-15T00:31:08-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300822</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300822</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Drugs: infectious diseases, Child health, Infant health, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Segmental percutaneous central venous line cultures for diagnosis of catheter-related sepsis]]></dc:title>
<prism:publicationDate>2011-12-15</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301251v1?rss=1">
<title><![CDATA[Survey of UK newborn resuscitation practices]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301251v1?rss=1</link>
<description><![CDATA[<p>Surveys of newborn resuscitation practices<cross-ref type="bib" refid="R1">1</cross-ref><cross-ref type="bib" refid="R2">&ndash;</cross-ref><cross-ref type="bib" refid="R3"></cross-ref><cross-ref type="bib" refid="R4">4</cross-ref> have revealed differences between and in countries, but the equipment and techniques used in the UK are guided by the UK Resuscitation Council, and staff involved must undertake a newborn life support course. We hypothesised, therefore, that in the UK there would be consistency of practice regardless of the level of neonatal care, and our aim was to test this hypothesis.</p><p>A questionnaire was sent to the lead paediatrician of 212 hospitals with newborn units. Differences in resuscitation practices according to the level of neonatal care were assessed for statistical significance using the <sup>2</sup> test.</p><p>There was an 85% response. The majority of hospitals were with neonatal intensive care units (NICUs) (93%) and local neonatal units (LNUs) (98%), but only 40% of those with special care units (SCUs) replied. In most hospitals (90%), resuscitation was performed in the delivery...]]></description>
<dc:creator><![CDATA[Murthy, V., Rao, N., Fox, G. F., Milner, A. D., Campbell, M., Greenough, A.]]></dc:creator>
<dc:date>2011-12-15T00:31:07-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301251</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301251</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Survey of UK newborn resuscitation practices]]></dc:title>
<prism:publicationDate>2011-12-15</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300097v1?rss=1">
<title><![CDATA[Multi-drug resistant gram negative bacilli causing early neonatal sepsis in India]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300097v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To study the organisms causing early and late onset neonatal sepsis, with special reference to multi-drug resistant gram negative bacilli, at two neonatal units (one urban, one rural) in India.</p></sec><sec><st>Methods</st><p>Prospective surveillance study.</p></sec><sec><st>Results</st><p>There were 159 episodes of sepsis (81 urban and 77 rural) affecting 158 babies. Gram negative bacilli caused 117 infections (68%) and predominated at both centres in both early and late sepsis. <I>Klebsiella pneumoniae</I> was the commonest organism, causing 61 infections (38.3%). In early sepsis (0&ndash;2 days), non-fermenting gram negative bacilli caused 42.1% of infections at the urban centre; there were no cases of early Group B Streptococcus sepsis. Late onset sepsis was mainly caused by gram negative bacilli at both centres. Multi-drug resistance of over 80% of early-onset gram negative organisms to ampicillin, third generation cephalosporins and gentamicin indicates that these multi-resistant organisms are almost certainly circulating widely in the community. The overall mortality from early sepsis was 27.3% (9 of 33) and from late sepsis was 26.2% (33 of 126). Gram negative bacilli caused all deaths from early sepsis and 87.5% of deaths from late sepsis.</p></sec><sec><st>Conclusion</st><p>This study shows that multi-drug resistant gram negative bacilli are a major cause of early and late neonatal sepsis in India and are almost certainly widespread in the community.</p></sec>]]></description>
<dc:creator><![CDATA[Viswanathan, R., Singh, A. K., Basu, S., Chatterjee, S., Sardar, S., Isaacs, D.]]></dc:creator>
<dc:date>2011-12-07T22:51:42-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300097</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300097</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Drugs: infectious diseases]]></dc:subject>
<dc:title><![CDATA[Multi-drug resistant gram negative bacilli causing early neonatal sepsis in India]]></dc:title>
<prism:publicationDate>2011-12-07</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300336v1?rss=1">
<title><![CDATA[Compressive force applied to a manikin's head during mask ventilation]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300336v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To investigate the compressive force applied to the head during mask ventilation and determine whether this force increases in response to an attempt to correct the mask leak.</p></sec><sec><st>Methods</st><p>The authors asked 24 participants (consultants, fellows and nurses) to administer positive pressure ventilation to a modified leak-free, term newborn manikin using a self-inflating bag (SIB) and a Neopuff T-piece device. Recordings were made before and after the participants were informed about their percentage of mask leak and asked to correct this. Airway pressure and flow were measured using a Florian monitor, and the force applied to the head was measured using a concealed custom-made load cell weighing scale.</p></sec><sec><st>Results</st><p>There were no differences in the mean (SD) force applied to the head between devices used and before or after the attempt to correct the mask leak (SIB before 2215 (892) and after 2195 (989) g; Neopuff before 1949 (957) and after 2028 (909) g). There was a large variation in force with both devices before and after the attempt (coefficient of variation: SIB before 40% and after 45%; Neopuff before 50% and after 45%). There was no correlation between mask leak and the difference in force used before and after the attempt to correct the mask leak using both devices.</p></sec><sec><st>Conclusion</st><p>During mask ventilation of a manikin, the authors observed that large forces were exerted on the head with either an SIB or a Neopuff, but these forces did not increase during the attempt to minimise the mask leak.</p></sec>]]></description>
<dc:creator><![CDATA[van Vonderen, J. J., Kleijn, T. A., Schilleman, K., Walther, F. J., Hooper, S. B., te Pas, A. B.]]></dc:creator>
<dc:date>2011-12-05T22:54:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300336</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300336</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Compressive force applied to a manikin's head during mask ventilation]]></dc:title>
<prism:publicationDate>2011-12-05</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300601v1?rss=1">
<title><![CDATA[Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300601v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To compare the effects of metoclopramide and domperidone on the breast milk output of mothers with infants in neonatal intensive care.</p></sec><sec><st>Design</st><p>Double-blind randomised controlled trial.</p></sec><sec><st>Setting</st><p>Tertiary level neonatal intensive care unit (NICU).</p></sec><sec><st>Sample</st><p>Eighty mothers expressing breast milk for their infants (mean gestational age 28 weeks) based in NICU and the amounts expressed fell short of the prescribed target.</p></sec><sec><st>Intervention</st><p>Mothers were randomised to receive domperidone or metoclopramide for 10 days (10 mg three times a day).</p></sec><sec><st>Outcome measures</st><p>Total milk volume daily for up to 10 days before the medication, 10 days during the trial and up to 10 days after medication. Adverse side effects were also recorded.</p></sec><sec><st>Results</st><p>Mothers produced more milk in the domperidone group and achieved a mean of 96.3% increase in milk volume (mean increase/pretrial volume) compared with a 93.7% increase for metoclopramide. After adjusting for the amount of milk produced prior to medication, the mean amount of milk produced while taking medication for those on domperidone was 31.0 ml/24 h (95% CI &ndash;5.67 to 67.6) greater than the mean for those on metoclopramide. Seven mothers taking metoclopramide reported side effects and three taking domperidone; a further eight women (of 29) who had a follow-on prescription for metoclopramide also reported side effects.</p></sec><sec><st>Conclusions</st><p>Oral domperidone and metoclopramide increased the volume of milk produced by mothers who are expressing to feed their babies in NICU. There were small differences in milk output between the two medications and in the incidence of side effects, but the differences were non-significant.</p></sec>]]></description>
<dc:creator><![CDATA[Ingram, J., Taylor, H., Churchill, C., Pike, A., Greenwood, R.]]></dc:creator>
<dc:date>2011-12-05T22:54:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300601</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300601</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Clinical trials (epidemiology), Childhood nutrition, Reproductive medicine, Child health, Infant nutrition (including breastfeeding), Neonatal and paediatric intensive care, Neonatal health, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial]]></dc:title>
<prism:publicationDate>2011-12-05</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300532v1?rss=1">
<title><![CDATA[Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300532v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To compare the efficacy and safety of oral versus intravenous ibuprofen for the pharmacological closure of patent ductus arteriosus (PDA) in less mature preterm infants.</p></sec><sec><st>Design</st><p>Prospective, randomised controlled study.</p></sec><sec><st>Setting</st><p>Tertiary neonatal intensive care unit.</p></sec><sec><st>Patients and interventions</st><p>The study enrolled 80 preterm infants with gestational age &le;28 weeks, birth weight &lt;1000 g, postnatal age 48 to 96 h, and had echocardiographically confirmed significant PDA. Seventy extremely low birthweight (ELBW) preterm infants received either intravenous or oral ibuprofen randomly as an initial dose of 10 mg/kg, followed by 5 mg/kg at 24 and 48 h.</p></sec><sec><st>Main outcome measures</st><p>The success rate and the safety of the drugs in ELBW preterm infants were the major outcomes.</p></sec><sec><st>Results</st><p>PDA closure rate was significantly higher with oral ibuprofen (83.3% vs 61.7%) after the first course of the treatment (p=0.04). Although the primary closure rate was marginally higher in the oral ibuprofen group, the need for a second course of ibuprofen during the whole hospitalisation was similar between groups: 11 of 36 in oral versus 15 of 34 in intravenous groups (p=0.24) because of a higher reopening rate in the oral group. In addition to no increase in side effects with oral ibuprofen use, the need for postnatal steroid use for chronic lung disease was significantly lower in oral ibuprofen group (p=0.001).</p></sec><sec><st>Conclusions</st><p>Oral ibuprofen is as effective as intravenous ibuprofen for PDA closure even in ELBW infants.</p></sec>]]></description>
<dc:creator><![CDATA[Erdeve, O., Yurttutan, S., Altug, N., Ozdemir, R., Gokmen, T., Dilmen, U., Oguz, S. S., Uras, N.]]></dc:creator>
<dc:date>2011-12-05T22:54:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300532</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300532</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Congenital heart disease, Child health, Infant health, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants]]></dc:title>
<prism:publicationDate>2011-12-05</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300557v1?rss=1">
<title><![CDATA[PHACES syndrome]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300557v1?rss=1</link>
<description><![CDATA[<p>An infant of 31 weeks' gestation was noted at birth to have a scar-like lesion extending from the umbilicus to the xiphisternum (<cross-ref type="fig" refid="F1">figure 1</cross-ref>).</p><p>An infantile haemangioma became apparent over her left face, extending into the mandibular area and lip, which gradually enlarged over the subsequent months (<cross-ref type="fig" refid="F2">figure 2</cross-ref>). At 3 years of age, the facial haemangioma has partially involuted.</p><p>She developed respiratory distress and stridor at 3 weeks of age. Microlaryngo-bronchoscopy showed a subglottic haemangioma extending down the trachea circumferentially towards the carina requiring tracheostomy formation (<cross-ref type="fig" refid="F3">figure 3</cross-ref>). She was successfully decannulated at 3 years of age after involution of the haemangioma.</p><p>Echocardiography and subsequent cardiac catheter study identified an aortic aneurysm (<cross-ref type="fig" refid="F4">figure 4</cross-ref>) requiring resection at 4 months of age.</p><p>PHACES syndrome is an uncommon neurocutaneous syndrome that manifests with multisystem involvement. It refers to the association of posterior fossa brain malformations, plaque-like segmental...]]></description>
<dc:creator><![CDATA[Mahadi, S., Malpas, T., O'Donnell, A., Roman, K., Jephson, C.]]></dc:creator>
<dc:date>2011-12-01T22:26:03-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300557</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300557</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Echocardiography, Radiology, Dermatology, Clinical diagnostic tests, Radiology (diagnostics), Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[PHACES syndrome]]></dc:title>
<prism:publicationDate>2011-12-01</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300647v1?rss=1">
<title><![CDATA[Effective ventilation at conventional rates with tidal volume below instrumental dead space: a bench study]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300647v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>The authors previously showed that 48% of infants &lt;800 g were ventilated with tidal volume (VT) &lt; dead space (DS) using volume guarantee (VG) ventilation. Here, The authors sought to confirm those findings under the rigorous conditions of a bench study.</p></sec><sec><st>Design and methods</st><p>The authors measured the time to wash out CO2 from a 45-ml test lung using end-tidal CO<SUB>2</SUB> monitor (ETCO<SUB>2</SUB>). The test lung was filled with 100% CO<SUB>2</SUB>, then ventilated using VG at VT ranging from DS+2 ml to DS&ndash;1.5 ml. With ventilation, ETCO<SUB>2</SUB> declined exponentially as CO<SUB>2</SUB> was washed out, the rate being proportional to VT &ndash; effective instrumental DS. The time from initiation of ventilation to threshold of accurate detection was determined in triplicate.</p></sec><sec><st>Results</st><p>Halving the theoretical &lsquo;alveolar ventilation&rsquo; (DS+2 ml to DS+1 ml) only increased the elimination time by 26%, not the 100%, as predicted by conventional physiology. CO<SUB>2</SUB> washout was less efficient, but still occurred even at VT=DS and VT=DS&ndash;1.5 ml. Halving the theoretical &lsquo;alveolar ventilation&rsquo; by decreasing respiratory rate from 80 to 40 breaths/min only increased elimination time by 35%, not 100%, as predicted by conventional physiology. Twenty minutes of continuous positive airway pressure prior to ventilation did not alter the elimination time, verifying that CO<SUB>2</SUB> did not diffuse or leak out of the test lung. Size of the endotracheal tube (ETT; 2.5, 3.0 and 3.5 mm) flow rate (4, 6 and 10 l/min) and inspiratory time (0.25 vs 0.35 s) did not affect the results.</p></sec><sec><st>Conclusions</st><p>Contrary to conventional physiology, effective CO<SUB>2</SUB> elimination appears to be possible with VT&lt;DS even at conventional rates. With small ETT a spike of fresh gas likely penetrates through the DS, rather than pushing it ahead.</p></sec>]]></description>
<dc:creator><![CDATA[Keszler, M., Montaner, M. B., Abubakar, K.]]></dc:creator>
<dc:date>2011-11-18T20:15:40-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300647</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300647</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Effective ventilation at conventional rates with tidal volume below instrumental dead space: a bench study]]></dc:title>
<prism:publicationDate>2011-11-18</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300548v1?rss=1">
<title><![CDATA[Neonatal resuscitation: are your trainees performing as you think they are? A retrospective review of a structured resuscitation assessment for neonatal medical trainees over an 8-year period]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300548v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To ascertain whether Newborn Life Support Course (NLS) accredited trainees could demonstrate resuscitation skills appropriate to their level of training by providing standardised assessments of both junior and senior paediatric trainees during their induction period.</p></sec><sec><st>Design</st><p>Retrospective review of medical staff resuscitation assessments over an 8-year period from 2003 to 2010.</p></sec><sec><st>Setting</st><p>A network-lead tertiary neonatal service with over 11 000 deliveries annually.</p></sec><sec><st>Participants</st><p>Neonatal medical staff: junior (speciality trainee(ST) of years 1&ndash;3) and senior trainees (ST 4&ndash;8 with tier 2 on-call responsibilities).</p></sec><sec><st>Intervention</st><p>A standardised criterion-referenced assessment was performed by two NLS instructors. Junior trainee assessment focused on the basic airway skills learnt on an NLS course. Senior trainees demonstrated resuscitation of a baby with meconium-stained liquor, focusing on advanced life support, including intubation of the mannequin.</p></sec><sec><st>Main outcome measures</st><p>Assessment outcomes were pass/fail; fails were categorised as algorithm failure, technical skills failure or both. For trainees who failed the first assessment, the outcome of the second assessment following appropriate feedback was recorded.</p></sec><sec><st>Results</st><p>Two hundred and sixty-two assessments were performed: 160 junior and 102 senior trainees; 98/160 (61%) of junior and 57/102 (56%) of senior trainees passed their first assessment; 69% of junior trainees who failed the first assessment had a second assessment recorded. There was a 79% pass rate at second assessment; 89% of senior trainees who failed a first assessment had a second assessment recorded. There was an 85% pass rate at second assessment. The majority of trainees who failed an assessment had problems with both the resuscitation algorithm and technical skills.</p></sec><sec><st>Conclusions</st><p>Significant numbers of trainees who have been formally trained in neonatal resuscitation skills previously do not pass the standardised resuscitation assessment, thus require an additional input to maintain their competence in neonatal resuscitation.</p></sec>]]></description>
<dc:creator><![CDATA[Cusack, J., Fawke, J.]]></dc:creator>
<dc:date>2011-11-17T22:01:13-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300548</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300548</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Resuscitation]]></dc:subject>
<dc:title><![CDATA[Neonatal resuscitation: are your trainees performing as you think they are? A retrospective review of a structured resuscitation assessment for neonatal medical trainees over an 8-year period]]></dc:title>
<prism:publicationDate>2011-11-17</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300356v1?rss=1">
<title><![CDATA[Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300356v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>Free-radical-induced reperfusion injury has been recognised as an important cause of brain tissue damage after birth asphyxia. Allopurinol reduces the formation of free radicals, thereby potentially limiting the amount of hypoxia&ndash;reperfusion damage. In this study the long-term outcome of neonatal allopurinol treatment after birth asphyxia was examined.</p></sec><sec><st>Design</st><p>Follow-up of 4 to 8 years of two earlier performed randomised controlled trials.</p></sec><sec><st>Setting</st><p>Leiden University Medical Center, University Medical Center Groningen and University Medical Center Utrecht, The Netherlands.</p></sec><sec><st>Patients</st><p>Fifty-four term infants were included when suffering from moderate-to-severe birth asphyxia in two previously performed trials.</p></sec><sec><st>Intervention</st><p>Infants either received 40 mg/kg allopurinol (with an interval of 12 h) starting within 4 h after birth or served as controls.</p></sec><sec><st>Main outcome measures</st><p>Children, who survived, were assessed with the Wechsler Preschool and Primary Scales of Intelligence test or Wechsler Intelligence Scale for Children and underwent a neurological examination. The effect of allopurinol on severe adverse outcome (defined as mortality or severe disability at the age of 4&ndash;8 years) was examined in the total group of asphyxiated infants and in a predefined subgroup of moderately asphyxiated infants (based on the amplitude integrated electroencephalogram).</p></sec><sec><st>Results</st><p>The mean age during follow-up (n=23) was 5 years and 5 months (SD 1 year and 2 months). There were no differences in long-term outcome between the allopurinol-treated infants and controls. However, subgroup analysis of the moderately asphyxiated group showed significantly less severe adverse outcome in the allopurinol-treated infants compared with controls (25% vs 65%; RR 0.40, 95%CI 0.17 to 0.94).</p></sec><sec><st>Conclusions</st><p>The reported data may suggest a (neuro)protective effect of neonatal allopurinol treatment in moderately asphyxiated infants.</p></sec>]]></description>
<dc:creator><![CDATA[Kaandorp, J. J., van Bel, F., Veen, S., Derks, J. B., Groenendaal, F., Rijken, M., Roze, E., Venema, M. M. U., Rademaker, C. M., Bos, A. F., Benders, M. J.]]></dc:creator>
<dc:date>2011-11-17T22:01:13-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300356</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300356</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Clinical trials (epidemiology), Epidemiologic studies, Drugs: cardiovascular system, Stroke, Developmental paediatrics, Trauma, Injury]]></dc:subject>
<dc:title><![CDATA[Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials]]></dc:title>
<prism:publicationDate>2011-11-17</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300627v1?rss=1">
<title><![CDATA[Early-onset group B Streptococcal sepsis: new recommendations from the Centres for Disease Control and Prevention]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300627v1?rss=1</link>
<description><![CDATA[<p>Since the early 1970s, group B Streptococcus (GBS) has been the leading cause of early-onset neonatal sepsis in the United States and many countries worldwide.<cross-ref type="bib" refid="R1">1</cross-ref> <cross-ref type="bib" refid="R2">2</cross-ref> Although the gastrointestinal tract is the primary source of genital colonisation, 10&ndash;30 per cent of women are colonised with GBS in their birth canal.<cross-ref type="bib" refid="R3">3</cross-ref> Pregnant women with GBS colonisation are 25 times more likely to deliver an infant with early-onset GBS sepsis than women who are culture negative.<cross-ref type="bib" refid="R4">4</cross-ref> Affected infants become colonised/infected during labour and delivery and present with respiratory distress or other signs of sepsis in the first 24&ndash;48 h of life. In 1996, the Centres for Disease Control in collaboration with representatives from the major physician organisations published initial recommendations for the prevention of early-onset GBS disease.<cross-ref type="bib" refid="R5">5</cross-ref> Those recommendations were modified in 2002 when universal screening of all pregnant women at 35&ndash;37...]]></description>
<dc:creator><![CDATA[Randis, T. M., Polin, R. A.]]></dc:creator>
<dc:date>2011-11-04T05:11:59-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300627</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300627</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Obstetrics and gynaecology, Immunology (including allergy), Drugs: infectious diseases, Pregnancy, Reproductive medicine, Screening (epidemiology), Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Early-onset group B Streptococcal sepsis: new recommendations from the Centres for Disease Control and Prevention]]></dc:title>
<prism:publicationDate>2011-11-04</prism:publicationDate>
<prism:section>Guideline reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300838v1?rss=1">
<title><![CDATA[Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300838v1?rss=1</link>
<description><![CDATA[<p>Studies on probiotics for prevention of necrotising enterocolitis (NEC) show a risk reduction across all studies from 6.6% (165/2493) in the untreated to 2.5% (62/2433) in the treated patients.<cross-ref type="bib" refid="R1">1</cross-ref> However, modest limitations in all studies, for example, uncharacteristically high-baseline rate of NEC<cross-ref type="bib" refid="R2">2</cross-ref>- warrant cautious risk&ndash;benefit consideration. This ambivalence is reflected by the current European Society of Paediatric Gastroenterology, Hepatology and Nutrition guidelines,<cross-ref type="bib" refid="R3">3</cross-ref> not officially recommending their use whereas a recent cochrane review<cross-ref type="bib" refid="R4">4</cross-ref> suggests a change in practice.</p><p>Monochorial-diamnial monocygotic twin pregnancy was diagnosed at 7 weeks gestational age (GA). Fetofetal transfusion syndrome was successfully treated with intrauterine laser ablation therapy at 16 weeks GA. At 27/5 weeks, caesarean section was performed due to premature rupture of membranes and uncontrollable labour. The index patient was born as the second twin weighing 600 g. Adaptation was uncomplicated; she received one dose of surfactant and was...]]></description>
<dc:creator><![CDATA[Jenke, A., Ruf, E.-M., Hoppe, T., Heldmann, M., Wirth, S.]]></dc:creator>
<dc:date>2011-11-04T05:11:58-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300838</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300838</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Journalology, Immunology (including allergy), Drugs: infectious diseases, Childhood nutrition, Pregnancy, Reproductive medicine, Childhood nutrition (paediatrics), Child health, Infant health, Infant nutrition (including breastfeeding), Neonatal health, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy]]></dc:title>
<prism:publicationDate>2011-11-04</prism:publicationDate>
<prism:section>Case reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300295v1?rss=1">
<title><![CDATA[Neonatal resuscitation assessment: documentation and early paging must be improved!]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300295v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>The authors had previously found flaws in resuscitation after severe neonatal asphyxia in cases selected on the grounds of suspected malpractice and financial compensation claims. The aim of the present study was to evaluate neonatal resuscitation in the general obstetric population in a setting with skilled attendance at birth.</p></sec><sec><st>Design</st><p>Observational study.</p></sec><sec><st>Setting and patients</st><p>All infants born in the Stockholm County during 2004&ndash;2006 with a gestational age of &ge;33 weeks, planned as vaginal delivery, with a normal cardiotocographic recording on admission to hospital and with an Apgar score of &lt;7 at 5 min were included.</p></sec><sec><st>Main outcome measures</st><p>Adherence to guidelines for neonatal resuscitation.</p></sec><sec><st>Results</st><p>Documentation was unsatisfactory in 142 (45%) infants. Other important shortcomings identified were delayed initiation of extensive resuscitation due to late paging or late arrival of attending paediatrician/neonatologist (n=48), and unsatisfactory ventilation related to late intubation and late securing of free airway (n=15).</p></sec><sec><st>Conclusions</st><p>Substandard care in neonatal resuscitation is not limited to cases of severe asphyxia related to claims for medical malpractice. The overall documentation of neonatal resuscitation needs to be much better to enable accurate and reliable evaluation. Obvious actions to improve standards of care include the paging of skilled personnel at an earlier stage in cases of complicated deliveries and team and skills training in neonatal ventilation.</p></sec>]]></description>
<dc:creator><![CDATA[Berglund, S., Norman, M.]]></dc:creator>
<dc:date>2011-10-27T11:46:25-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300295</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300295</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Unlocked, Child health, Resuscitation, Trauma, Legal and forensic medicine, Injury]]></dc:subject>
<dc:title><![CDATA[Neonatal resuscitation assessment: documentation and early paging must be improved!]]></dc:title>
<prism:publicationDate>2011-10-27</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300213v1?rss=1">
<title><![CDATA[Reversal of morphine-induced urinary retention after methylnaltrexone]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300213v1?rss=1</link>
<description><![CDATA[<p>Methylnaltrexone, a peripherally acting &micro;-opioid receptor antagonist, has been studied in adults for the treatment of opioid-induced constipation in advanced illness. Here, the authors document the first neonate to receive methylnaltrexone in an attempt to resolve morphine-induced urinary retention. An asphyxiated term newborn infant underwent induced hypothermia and received morphine by continuous intravenous infusion. After 36 h, the patient developed progressive urinary retention (calculated bladder volume 63 ml), followed by venous congestion of the lower extremities. Attempted bladder catheterisation was unsuccessful. Voiding occurred within 20 min after intravenous administration of methylnaltrexone (0.15 mg/kg body weight). A relapse of urinary retention 24 h later responded well to a second dose of methylnaltrexone. There were no adverse effects and no opioid withdrawal symptoms. The neonate had normal findings in cranial MRI that was performed after elective cessation of induced hypothermia.</p>]]></description>
<dc:creator><![CDATA[Garten, L., Buhrer, C.]]></dc:creator>
<dc:date>2011-10-27T11:46:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300213</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300213</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Constipation, Urology, Child health, Unwanted effects / adverse reactions, Drugs misuse (including addiction)]]></dc:subject>
<dc:title><![CDATA[Reversal of morphine-induced urinary retention after methylnaltrexone]]></dc:title>
<prism:publicationDate>2011-10-27</prism:publicationDate>
<prism:section>Case reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300121v1?rss=1">
<title><![CDATA[DTI reveals network injury in perinatal stroke]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300121v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>Previous research showed acute diffusion-weighted imaging changes in pulvinar after extensive cortical injury from neonatal stroke. The authors used diffusion tensor imaging (DTI) to see how separate regions of ipsilateral thalamus are directly affected after a primary hit to their connected cortex in neonatal stroke.</p></sec><sec><st>Methods</st><p>The authors analysed DTI images of three term infants with acute unilateral cortical arterial ischaemic stroke. Probabilistic tractography was used to define separate thalamic regions of interests (ROIs). The authors evaluated the three eigenvalues (EV) and apparent diffusion coefficient (ADC) values in the ROIs.</p></sec><sec><st>Results</st><p>The ADC and EV in voxels of ROIs placed within the nuclei corresponding to ischaemic cortex were significantly lower than those in the unaffected contralesional thalamic nuclei.</p></sec><sec><st>Conclusions</st><p>Our findings support the concept of acute network injury in neonatal stroke. ADC and EV were altered in specific thalamic regions that corresponded to the specific cortical areas affected by the primary ischaemic injury.</p></sec>]]></description>
<dc:creator><![CDATA[Dudink, J., Counsell, S. J., Lequin, M. H., Govaert, P. P.]]></dc:creator>
<dc:date>2011-10-20T05:25:25-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300121</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300121</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Stroke, Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[DTI reveals network injury in perinatal stroke]]></dc:title>
<prism:publicationDate>2011-10-20</prism:publicationDate>
<prism:section>Short research reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300235v1?rss=1">
<title><![CDATA[Dopamine D2 receptor gene polymorphisms in newborn infants of drug-using women]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300235v1?rss=1</link>
<description><![CDATA[<sec><st>Objectives</st><p>To determine the characteristics of dopamine D2 receptor gene (DRD2) polymorphisms in drug-exposed and unexposed neonates and the relationship to neonatal abstinence syndrome (NAS).</p></sec><sec><st>Design</st><p>Retrospective case-control analysis between drug-exposed and unexposed infants between DRD2 polymorphisms, drug exposure and NAS treatment.</p></sec><sec><st>Patients</st><p>Drug-exposed (n=48) and drug-free (n=49) infants born between March 1999 and December 2006.</p></sec><sec><st>Methods</st><p>Analysis of DNA for the Taq1A, -141Ins/Del and Ser311Cys DRD2 polymorphisms. Drug exposure was determined by antenatal maternal drug and alcohol history. Frequency measures of DRD2 polymorphisms were compared between drug-exposed infants, treatment NAS medication and with control infants.</p></sec><sec><st>Setting</st><p>Tertiary maternity hospital, Sydney, Australia.</p></sec><sec><st>Main outcome measures</st><p>All infants were born in a good condition (25.7% &lt;37 weeks gestation). Opiates (methadone and heroin) were used by 45 (93.8%) of drug-exposed mothers. The A2A2 allele was more common in drug-exposed infants (37 (77.0%) versus 23 (46.9%), p=0.003) but the A1A2 allele was more common in control infants (23 (46.9%) versus 4 (8.3%), p=0.00002). The-ins allele was more common in control (39 (79.6%) versus 20 (41.7%), p=&lt;0.01) and unmedicated drug-exposed (14/25 (56%) versus 5/23 (21.7%), p=0.02) infants. The majority of infants (41 (83.7%) controls versus 41 (85.4%), p=1.000) expressed the least common, Ser polymorphism.</p></sec><sec><st>Conclusions</st><p>DRD2 polymorphisms are detectable from DNA obtained from stored blood spots. The &ndash;ins allele is more common in control and unmedicated drug-exposed infants. Further study is recommended to explore postneonatal outcomes especially in relation to neuropsychiatric behaviours.</p></sec>]]></description>
<dc:creator><![CDATA[Oei, J. L., Xu, H. X., Abdel-Latif, M. E., Vunnam, K., Al-Amry, A., Clews, S., Falconer, J., Feller, J. M., Lui, K.]]></dc:creator>
<dc:date>2011-09-26T03:42:45-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300235</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300235</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Molecular genetics, Drugs: CNS (not psychiatric)]]></dc:subject>
<dc:title><![CDATA[Dopamine D2 receptor gene polymorphisms in newborn infants of drug-using women]]></dc:title>
<prism:publicationDate>2011-09-26</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300573v1?rss=1">
<title><![CDATA[The state of neonatal transport services in the UK]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300573v1?rss=1</link>
<description><![CDATA[<p>Neonatal transfer services across the UK have evolved at different rates, using a variety of approaches. Scotland, Northern Ireland and most recently Wales have adopted a more centralised approach than in England, where due to comparative population size transport services have developed alongside neonatal network boundaries. Despite considerable investment, transport provision remains variable in some areas and there are continuing issues common to most regions, including service provision and configuration, training, competencies and audit. Further development is required to optimise the use of available resources and develop benchmarking to ensure a high quality sustainable service.</p>]]></description>
<dc:creator><![CDATA[Fenton, A. C., Leslie, A.]]></dc:creator>
<dc:date>2011-09-26T03:42:45-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300573</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300573</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[The state of neonatal transport services in the UK]]></dc:title>
<prism:publicationDate>2011-09-26</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300635v1?rss=1">
<title><![CDATA[Neonatal intensive care unit safety culture varies widely]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300635v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>Variation in healthcare delivery and outcomes in neonatal intensive care units (NICUs) may be partly explained by differences in safety culture.</p></sec><sec><st>Objective</st><p>To describe NICU care giver assessments of safety culture, explore variability within and between NICUs on safety culture domains, and test for association with care giver characteristics.</p></sec><sec><st>Methods</st><p>NICU care givers in 12 hospitals were surveyed using the Safety Attitudes Questionnaire (SAQ), which has six scales: teamwork climate, safety climate, job satisfaction, stress recognition, perception of management and working conditions. Scale means, SDs and percent positives (percent agreement) were calculated for each NICU.</p></sec><sec><st>Results</st><p>There was substantial variation in safety culture domains among NICUs. Composite mean score across the six domains ranged from 56.3 to 77.8 on a 100-point scale and NICUs in the top four NICUs were significantly different from the bottom four (p&lt;0.001). Across the six domains, respondent assessments varied widely, but were least positive on perceptions of management (3%&ndash;80% positive; mean 33.3%) and stress recognition (18%&ndash;61% positive; mean 41.3%). Comparisons of SAQ scale scores between NICUs and a previously published adult ICU cohort generally revealed higher scores for NICUs. Composite scores for physicians were 8.2 (p=0.04) and 9.5 (p=0.02) points higher than for nurses and ancillary personnel.</p></sec><sec><st>Conclusion</st><p>There is significant variation and scope for improvement in safety culture among these NICUs. The NICU variation was similar to variation in adult ICUs, but NICU scores were generally higher. Future studies should validate whether safety culture measured with the SAQ correlates with clinical and operational outcomes in NICUs.</p></sec>]]></description>
<dc:creator><![CDATA[Profit, J., Etchegaray, J., Petersen, L. A., Sexton, J. B., Hysong, S. J., Mei, M., Thomas, E. J.]]></dc:creator>
<dc:date>2011-09-19T09:30:43-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300635</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300635</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Nursing, Neonatal and paediatric intensive care, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[Neonatal intensive care unit safety culture varies widely]]></dc:title>
<prism:publicationDate>2011-09-19</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.300492v1?rss=1">
<title><![CDATA[Milk osmolality: does it matter?]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.300492v1?rss=1</link>
<description><![CDATA[<p>High osmolality of infant feed reflects a high concentration of solute particles and has been implicated as a cause of necrotising enterocolitis. Evidence for direct intestinal mucosal injury as a result of hyperosmolar feeds is scant, and no good evidence has been found to support such an association. High osmolality of enteral substrate may, however, slow down gastric emptying. Osmolality of current infant feeds ranges from around 300 mOsm/kg in human breast milk to just more than 400 mOsm/kg in fully fortified breast milk. Addition of mineral and vitamin supplements to small volumes of milk can increase osmolality significantly and should be avoided if possible.</p>]]></description>
<dc:creator><![CDATA[Pearson, F., Johnson, M. J., Leaf, A. A.]]></dc:creator>
<dc:date>2011-09-19T07:25:37-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.300492</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.300492</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Milk osmolality: does it matter?]]></dc:title>
<prism:publicationDate>2011-09-19</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.300224v1?rss=1">
<title><![CDATA[Neonatal nurse staffing and delivery of clinical care in the SSBC Newborn Network]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.300224v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To measure nursing workload and timely completion of essential tasks in relation to the staffing levels recommended by the British Association of Perinatal Medicine (BAPM) in Staffordshire, Shropshire and Black CountryNewborn Network.</p></sec><sec><st>Methods</st><p>A prospective observational study was conducted measuring the time taken by selected nurses to undertake the necessary tasks for babies receiving different levels of care in the Network's six constituent neonatal units. An independent observer was used. The unit and individual's workload was evaluated against BAPM standards. Delays in essential predetermined tasks were recorded. The impact on quantity of care given and on the number of delayed tasks were compared between those with the recommended workload or less and those overstretched.</p></sec><sec><st>Results</st><p>Between October 2008 and February 2009, 89 nurses were observed caring for 244 neonates over 534 h. 54% of nursing shifts failed to meet BAPM standards. Nurses with workload greater than the BAPM-recommended levels demonstrated a 28% decrease in median time spent on clinical care per baby. 92 (17%) essential tasks were delayed &gt;1 h or not done. Delays/omissions were more likely when BAPM standards were not met (53% vs 40%, p=0.049). In nursing observations without delays/omissions, accommodating for adequate nursing breaks and working in the same area, nurses could cater for no more than 1.2, 1.5 and 2.7 babies in intensive care, high dependency care and special care, respectively.</p></sec><sec><st>Conclusion</st><p>Understaffing leads to measurable problems including delays to essential treatment and reduced clinical care. BAPM standards are not aspirational and should be regarded as a minimum. Further research on optimising nursing care efficiency with limited nursing resources is necessary.</p></sec>]]></description>
<dc:creator><![CDATA[Pillay, T., Nightingale, P., Owen, S., Kirby, D., Spencer, A.]]></dc:creator>
<dc:date>2011-09-19T07:25:36-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.300224</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.300224</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Nursing, Child health, Neonatal and paediatric intensive care, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Neonatal nurse staffing and delivery of clinical care in the SSBC Newborn Network]]></dc:title>
<prism:publicationDate>2011-09-19</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.212001v2?rss=1">
<title><![CDATA[Fitness to fly testing in term and ex-preterm babies without bronchopulmonary dysplasia]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.212001v2?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>During air flight, cabin pressurisation produces an effective fraction of inspired oxygen (FiO<SUB>2</SUB>) of 0.15. This can cause hypoxia in predisposed individuals, including infants with bronchopulmonary dysplasia (BPD), but the effect on ex-preterm babies without BPD was uncertain. The consequences of feeding a baby during the hypoxia challenge were also unknown.</p></sec><sec><st>Methods</st><p>Ex-preterm (without BPD) and term infants had fitness to fly tests (including a period of feeding) at 3 or 6 months corrected gestational age (CGA) in a body plethysmograph with an FiO<SUB>2</SUB> of 0.15 for 20 min. A &lsquo;failed&rsquo; test was defined as oxygen saturation (SpO<SUB>2</SUB>) &lt;90% for at least 2 min.</p></sec><sec><st>Results</st><p>41 term and 30 ex-preterm babies (mean gestational age 39.8 and 33.1 weeks, respectively) exhibited a significant median drop in SpO<SUB>2</SUB> (median &ndash;6%, p&lt;0.0001); there was no difference between term versus ex-preterm babies, or 3 versus 6 months. Two term (5%) and two ex-preterm (7%) babies failed the challenge. The SpO<SUB>2</SUB> dropped further during feeding (median &ndash;4% in term and &ndash;2% in ex-preterm, p&lt;0.0001), with transient desaturation (up to 30 s) &lt;90% seen in 8/36 (22%) term and 9/28 (32%) ex-preterm infants; the ex-preterm babies desaturated more quickly (median 1 vs 3 min, p=0.002).</p></sec><sec><st>Conclusions</st><p>Ex-preterm babies without BPD and who are at least 3 months CGA do not appear to be a particularly at-risk group for air travel, and routine preflight testing is not indicated. Feeding babies in an FiO<SUB>2</SUB> of 0.15 leads to a further fall in SpO<SUB>2</SUB>, which is significant but transient.</p></sec>]]></description>
<dc:creator><![CDATA[Bossley, C. J., Cramer, D., Mason, B., Hayward, A., Smyth, J., McKee, A., Biddulph, R., Ogundipe, E., Jaffe, A., Balfour-Lynn, I. M.]]></dc:creator>
<dc:date>2011-09-13T06:36:24-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.212001</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.212001</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Bronchopulmonary dysplasia]]></dc:subject>
<dc:title><![CDATA[Fitness to fly testing in term and ex-preterm babies without bronchopulmonary dysplasia]]></dc:title>
<prism:publicationDate>2011-09-13</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300143v1?rss=1">
<title><![CDATA[Prediction of survival without morbidity for infants born at under 33 weeks gestational age: a user-friendly graphical tool]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300143v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To develop models and a graphical tool for predicting survival to discharge without major morbidity for infants with a gestational age (GA) at birth of 22&ndash;32 weeks using infant information at birth.</p></sec><sec><st>Design</st><p>Retrospective cohort study.</p></sec><sec><st>Setting</st><p>Canadian Neonatal Network data for 2003&ndash;2008 were utilised.</p></sec><sec><st>Patients</st><p>Neonates born between 22 and 32 weeks gestation admitted to neonatal intensive care units in Canada.</p></sec><sec><st>Main outcome measure</st><p>Survival to discharge without major morbidity defined as survival without severe neurological injury (intraventricular haemorrhage grade 3 or 4 or periventricular leukomalacia), severe retinopathy (stage 3 or higher), necrotising enterocolitis (stage 2 or 3) or chronic lung disease.</p></sec><sec><st>Results</st><p>Of the 17 148 neonates who met the eligibility criteria, 65% survived without major morbidity. Sex and GA at birth were significant predictors. Birth weight (BW) had a significant but non-linear effect on survival without major morbidity. Although maternal information characteristics such as steroid use, improved the prediction of survival without major morbidity, sex, GA at birth and BW for GA predicted survival without major morbidity almost as accurately (area under the curve: 0.84). The graphical tool based on the models showed how the GA and BW for GA interact, to enable prediction of outcomes especially for small and large for GA infants.</p></sec><sec><st>Conclusion</st><p>This graphical tool provides an improved and easily interpretable method to predict survival without major morbidity for very preterm infants at the time of birth. These curves are especially useful for small and large for GA infants.</p></sec>]]></description>
<dc:creator><![CDATA[Shah, P. S., Ye, X. Y., Synnes, A., Rouvinez-Bouali, N., Yee, W., Lee, S. K., the Canadian Neonatal Network]]></dc:creator>
<dc:date>2011-09-06T22:43:50-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300143</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300143</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Child health, Neonatal and paediatric intensive care, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Prediction of survival without morbidity for infants born at under 33 weeks gestational age: a user-friendly graphical tool]]></dc:title>
<prism:publicationDate>2011-09-06</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300641v1?rss=1">
<title><![CDATA[What are the main research findings during the last 5 years that have changed my approach to clinical practice?]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300641v1?rss=1</link>
<description><![CDATA[
<p>When asked to address the above question, findings that appeared to be among the most relevant included (1) interventions in the delivery room directed at supporting the physiological transition from intrauterine to extrauterine life rather than actively intervening in it; (2) recent data suggesting that keeping extremely low-gestational age neonates at a pulse oximeter saturation (SpO<SUB>2</SUB>) of 91&ndash;95% would increase their chances of survival compared with aiming for lower SpO<SUB>2</SUB> values; (3) using caffeine citrate in infants &lt;1250 g with apnoea of prematurity improves neurodevelopmental outcome; (4) injecting antivascular epithelial growth factor into the vitreous seems to be an effective treatment for retinopathy of prematurity and (5) moderate hypothermia for perinatal hypoxic-ischaemic encephalopathy increases the likelihood of survival without neurological impairment. Here, data that support these recent changes in approach will be presented and discussed.</p>
]]></description>
<dc:creator><![CDATA[Poets, C. F.]]></dc:creator>
<dc:date>2011-08-24T09:36:47-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300641</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300641</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[What are the main research findings during the last 5 years that have changed my approach to clinical practice?]]></dc:title>
<prism:publicationDate>2011-08-24</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300535v1?rss=1">
<title><![CDATA[Born just a few weeks early: does it matter?]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300535v1?rss=1</link>
<description><![CDATA[
<p>Until recently, infants born at moderate preterm (32&ndash;33 weeks) and late preterm (34&ndash;36 weeks) gestations have gone largely unstudied. Since their outcomes were thought to be similar to those of infants born at 37 weeks and above, they have historically been managed in much the same way as infants born at term. However, accumulating data indicate that risks of morbidity and mortality are significantly greater in this group than previously believed. Since moderate and late preterm infants account for around 6% of all births, very large numbers of babies are potentially affected. Although their problems may be less obvious than those of extremely preterm infants, the population impact of long-term health and neurodevelopmental problems in this group will be substantial. This review summarises the current available literature, highlights gaps in knowledge and discusses the implications of late preterm birth for both clinical practice and research in the perinatal period and beyond.</p>
]]></description>
<dc:creator><![CDATA[Boyle, J. D., Boyle, E. M.]]></dc:creator>
<dc:date>2011-08-24T09:36:46-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300535</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300535</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Born just a few weeks early: does it matter?]]></dc:title>
<prism:publicationDate>2011-08-24</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.215160v2?rss=1">
<title><![CDATA[Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.215160v2?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Oral ibuprofen has been shown to be associated with excellent patent ductus arteriosus (PDA) closure rates and a favourable safety profile, but limited data exist regarding its pharmacokinetics in preterm infants.</p>
</sec>
<sec><st>Objective</st>
<p>To evaluate pharmacokinetic parameters of oral ibuprofen in preterm infants.</p>
</sec>
<sec><st>Methods</st>
<p>Plasma ibuprofen levels were determined at various time points, and pharmacokinetic profiles were calculated after a single dose of 10 mg/kg of oral ibuprofen. The rate of ductal closure, adverse effects and patients' clinical course were recorded.</p>
</sec>
<sec><st>Results</st>
<p>The authors studied 13 preterm infants (mean gestational age&plusmn;SD 27.8&plusmn;2.4 weeks, mean birth weight 1052&plusmn;443 g). PDA closure was obtained in all patients after a single dose. Ibuprofen levels were detectable 1 h after administration, peaked after 8 h and remained in a relative plateau until 24 h postadministration. Area under the curve (AUC)0-&gt;24 was higher than levels reported with intravenous treatment. No adverse effects were observed.</p>
</sec>
<sec><st>Conclusion</st>
<p>Oral administration of ibuprofen in very preterm infants is associated with excellent absorption and a high AUC0-&gt;24, and may be an alternative to intravenous administration.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Barzilay, B., Youngster, I., Batash, D., Keidar, R., Baram, S., Goldman, M., Berkovitch, M., Heyman, E.]]></dc:creator>
<dc:date>2011-08-17T07:43:39-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.215160</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.215160</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Congenital heart disease, Child health, Infant health, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants]]></dc:title>
<prism:publicationDate>2011-08-17</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.209700v1?rss=1">
<title><![CDATA[How reliably can paediatric professionals identify pale stool from cholestatic newborns?]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.209700v1?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>The success of surgery in infants with hepatobiliary disease is inversely proportional to the age when surgery was performed. Pale stool colour is a major indicator of biliary obstruction. However, simple recognition has been inadequate, resulting in late diagnosis and referral.</p>
<p>Objective To assess the skills of healthcare professionals in recognising pale stools.</p>
</sec>
<sec><st>Method</st>
<p>Photographs of normal, acholic and indeterminate infant stools were shown to paediatric professionals who have regular contact with jaundiced babies at three London teaching hospitals. Each stool was classified as &lsquo;healthy&rsquo; or &lsquo;suspect&rsquo;.</p>
</sec>
<sec><st>Results</st>
<p>One-third of the stools were not correctly identified by physicians and nurses.</p>
</sec>
<sec><st>Conclusion</st>
<p>Experienced professionals often do not recognise stool colour associated with biliary obstruction. The authors propose that stool colour cards similar to those used in Japan and Taiwan may improve early detection of hepatobiliary disease at a minimal cost.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Bakshi, B., Sutcliffe, A., Akindolie, M., Vadamalayan, B., John, S., Arkley, C., Griffin, L. D., Baker, A.]]></dc:creator>
<dc:date>2011-08-17T20:02:21-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.209700</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.209700</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[How reliably can paediatric professionals identify pale stool from cholestatic newborns?]]></dc:title>
<prism:publicationDate>2011-08-17</prism:publicationDate>
<prism:section>Guideline reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.196451v1?rss=1">
<title><![CDATA[Neonatal stroke]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.196451v1?rss=1</link>
<description><![CDATA[
<p>Neonatal stroke encompasses a range of focal and multifocal ischaemic and haemorrhagic tissue injuries. This review will concentrate on focal brain injury that occurs as a consequence of arterial infarction, most frequently the left middle cerebral artery, or more rarely as a consequence of cerebral sinus venous thrombosis (CSVT). Both conditions are multifactorial in origin. The incidence of both acquired and genetic thrombophilic disorders in both mothers and infants is high although rarely causal in isolation. Neurodevelopmental morbidity occurs in over 50% of children. Specific therapy in the form of anticoagulation is currently only recommended in CSVT and needs to be carefully monitored in the presence of haemorrhage.</p>
]]></description>
<dc:creator><![CDATA[Rutherford, M. A., Ramenghi, L. A., Cowan, F. M.]]></dc:creator>
<dc:date>2011-08-17T20:02:23-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.196451</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.196451</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Neonatal stroke]]></dc:title>
<prism:publicationDate>2011-08-17</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.213587v2?rss=1">
<title><![CDATA[Transferring preterm infants from incubators to open cots at 1600 g: a multicentre randomised controlled trial]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.213587v2?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To determine the effects on weight gain and temperature control of transferring preterm infants from incubators to open cots at a weight of 1600 g versus a weight of 1800 g.</p>
</sec>
<sec><st>Design</st>
<p>Randomised controlled trial.</p>
</sec>
<sec><st>Setting</st>
<p>One tertiary and two regional neonatal units in public hospitals in Queensland, Australia.</p>
</sec>
<sec><st>Participants</st>
<p>182 preterm infants born with a birth weight less than 1600 g, who were at least 48 h old; had not required ventilation or continuous positive airways pressure within the last 48 h; were medically stable with no oxygen requirement, or significant apnoea or bradycardia; did not require phototherapy; and were enterally fed with an intake (breast milk/formula) of at least 60 ml/kg/day.</p>
</sec>
<sec><st>Interventions</st>
<p>Transfer into an open cot at 1600 or 1800 g.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>The primary outcomes were temperature stability and average daily weight gain over the first 14 days following transfer to an open cot.</p>
</sec>
<sec><st>Results</st>
<p>90 infants in the 1600 g group and 92 infants in the 1800 g group were included in the analysis. Over the first 72 h, more infants in the 1800 g group had temperatures &lt;36.4&deg;C than the 1600 g group (p=0.03). From post-transfer to discharge, the 1600 g group had more temperatures &gt;37.1&deg;C (p=0.02). Average daily weight gain in the 1600 g group was 17.07 (SD&plusmn;4.5) g/kg/day and in the 1800 g group, 13.97 (SD&plusmn;4.7) g/kg/day (p=&lt;0.001).</p>
</sec>
<sec><st>Conclusions</st>
<p>Medically stable, preterm infants can be transferred to open cots at a birth weight of 1600 g without any significant adverse effects on temperature stability or weight gain.</p>
</sec>
<sec><st>Trial registration:</st>
<p>ACTRN12606000518561 (<A HREF="http://www.anzctr.org.au">http://www.anzctr.org.au</A>).</p>
</sec>
]]></description>
<dc:creator><![CDATA[New, K., Flint, A., Bogossian, F., East, C., Davies, M. W.]]></dc:creator>
<dc:date>2011-08-13T05:12:30-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.213587</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.213587</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Clinical trials (epidemiology), Drugs: cardiovascular system, Child health, Infant health, Neonatal health, Physiotherapy, Arrhythmias]]></dc:subject>
<dc:title><![CDATA[Transferring preterm infants from incubators to open cots at 1600 g: a multicentre randomised controlled trial]]></dc:title>
<prism:publicationDate>2011-08-13</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300357v1?rss=1">
<title><![CDATA[Unilateral radial nerve palsy in a newborn]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300357v1?rss=1</link>
<description><![CDATA[ <p>A male neonate, born by normal vaginal delivery, was noticed to have a right wrist drop during the first day baby check (<cross-ref type="fig" refid="F1">figure 1</cross-ref>). Wrist extension, finger extension and the palmar grasp reflex were absent on the ipsilateral side and normal on the contralateral side. A red indurated area above the right lateral humeral epicondyle was noticed (<cross-ref type="fig" refid="F1">figure 1</cross-ref>). An upper limb x-ray excluded fracture. Subcutaneous fat necrosis with radial nerve palsy secondary to intrauterine compression was considered due to the anatomical association.</p> <p>MRI of the right elbow confirmed the clinical diagnosis by showing an area of subcutaneous fat necrosis and a deep seated small haematoma where the radial nerve would pass (<cross-ref type="fig" refid="F2">figure 2</cross-ref>).</p> <p>A wrist splint was provided by physiotherapy and was only used for a few days. Follow-up at 2 months revealed full recovery of the elbow lesion and wrist drop....]]></description>
<dc:creator><![CDATA[Ghinescu, C. E., Kamalanathan, A. N., Morgan, C.]]></dc:creator>
<dc:date>2011-08-10T23:25:16-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300357</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300357</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Unilateral radial nerve palsy in a newborn]]></dc:title>
<prism:publicationDate>2011-08-10</prism:publicationDate>
<prism:section>Miscellanea</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.210740v1?rss=1">
<title><![CDATA[Nitrous oxide analgesia during retinopathy screening: a randomised controlled trial]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.210740v1?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To determine if the addition of an inhaled equimolar mixture of nitrous oxide (N<SUB>2</SUB>O) and oxygen (EMONO) would produce superior pain relief to standard pharmacological and non-pharmacological measures during eye examination screening for retinopathy of prematurity (ROP) in premature infants.</p>
</sec>
<sec><st>Study design</st>
<p>A randomised, double-blind controlled trial was conducted.</p>
</sec>
<sec><st>Setting</st>
<p>Royal Victoria Hospital, a tertiary neonatal intensive care unit in Montreal, Canada.</p>
</sec>
<sec><st>Patients</st>
<p>Stable spontaneously breathing premature infants with birth weights less than 1500 g or gestation of 30 weeks and less.</p>
</sec>
<sec><st>Intervention</st>
<p>During the eye examination, all infants were swaddled, received oral sucrose and topical anaesthetics. Control group infants received a mixture of 50% oxygen and 50% nitrogen (n=18) administered by nasal cannula, while the intervention group received EMONO (50% oxygen and 50% N<SUB>2</SUB>O).</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Pain was assessed by the premature infant pain profile (PIPP).</p>
</sec>
<sec><st>Results</st>
<p>The mean PIPP score at speculum insertion in the control group (8.4, 95% CI 7.6 to 9.3) was comparable with the EMONO group (8.5, 95% CI 7.3 to 9.8) with a p value of 0.94. There were no significant differences in heart rate or saturation between the two groups. EMONO inhalation was tolerated without any measured side effects.</p>
</sec>
<sec><st>Conclusion</st>
<p>EMONO does not produce any additional pain relief over currently used measures during ROP screening eye examinations. Systematically combining pharmacological and non-pharmacological treatment modalities appears to be the best option until newer treatments are proven effective.</p>
</sec>
<sec><st>Clinical trials registration number</st>
<p>NCT00623220</p>
</sec>
]]></description>
<dc:creator><![CDATA[Mandel, R., Ali, N., Chen, J., Galic, I. J., Levesque, L.]]></dc:creator>
<dc:date>2011-08-10T23:25:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.210740</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.210740</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Eye Diseases, Clinical trials (epidemiology), Pain (neurology), Ophthalmology, Child health, Infant health, Neonatal and paediatric intensive care, Neonatal health, Pain (palliative care), Screening (epidemiology), Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Nitrous oxide analgesia during retinopathy screening: a randomised controlled trial]]></dc:title>
<prism:publicationDate>2011-08-10</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.210856v1?rss=1">
<title><![CDATA[Actuarial day-by-day survival rates of preterm infants admitted to neonatal intensive care in New South Wales and the Australian Capital Territory]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.210856v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To characterise the actuarial day-by-day survival of premature infants in a geographically defined population.</p>
</sec>
<sec><st>Setting</st>
<p>10 Neonatal Intensive Care Units (NICUs) in New South Wales (NSW) and Australian Capital Territory (ACT), Australia.</p>
</sec>
<sec><st>Design</st>
<p>Retrospective analysis of prospectively collected data as part of NICUs' data collection in NSW and ACT.</p>
</sec>
<sec><st>Subjects</st>
<p>Premature infants born at 22<sup>+0</sup> to 31<sup>+6</sup> weeks' gestation between January 1997 and December 2006 and admitted to one of the 10 NICUs in NSW and ACT.</p>
</sec>
<sec><st>Outcome</st>
<p>Actuarial day-by-day survival to discharge from NICU.</p>
</sec>
<sec><st>Results</st>
<p>Survival to discharge after initiation of neonatal intensive care ranges from 30.0% at 23 weeks' gestation to 98.8% at 31 weeks. Actuarial day-by-day survival increased across all gestations. This improvement was most notable among the babies who were born &lt;26 weeks gestation.</p>
</sec>
<sec><st>Conclusion</st>
<p>Preterm infants who survive the first few postnatal days have considerable chances of long-term survival. It is important to revise the information stored regarding chances of survival so it covers chances at regular intervals, especially after the first few days of life.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Abdel-Latif, M. E., Kecskes, Z., Bajuk, B., On behalf of the NSW and the ACT Neonatal Intensive Care Audit Group]]></dc:creator>
<dc:date>2011-08-09T23:56:06-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.210856</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.210856</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Infant health, Neonatal and paediatric intensive care, Neonatal health, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[Actuarial day-by-day survival rates of preterm infants admitted to neonatal intensive care in New South Wales and the Australian Capital Territory]]></dc:title>
<prism:publicationDate>2011-08-09</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.214239v1?rss=1">
<title><![CDATA[Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.214239v1?rss=1</link>
<description><![CDATA[
<p>Selective serotonin reuptake inhibitors (SSRIs) are increasingly used during pregnancy and lactation, with 1.8&ndash;2.8% exposed pregnancies. Given the risks of untreated maternal depression for both mother and child, adequate treatment is essential. If pharmacological treatment with SSRIs is indicated, the fetal and neonatal effects of SSRIs have to be considered, as SSRIs cross the placenta and are excreted into breast milk. The overall risk of major congenital malformations during SSRI exposure in the first trimester does not appear to be greatly increased. Depending on the variability in pharmacokinetic properties between the different SSRIs and the individual drug metabolism of mother and child, SSRI exposure during late pregnancy can lead to serotonin reuptake inhibitor-related symptoms in up to 30% of exposed infants postnatally. Symptoms are generally mild and self-limited, but need observation during at least 48 h as some infants develop severe symptoms needing intervention. Limited data are available about the long-term neurodevelopmental outcomes after SSRI exposure during pregnancy and lactation, but currently, cognitive development seems normal, while behavioural abnormalities may be increased.</p>
<p>In this article, the available clinical data are reviewed. Additionally, the authors provide a multidisciplinary guideline for the monitoring and management of neonates exposed to SSRIs during pregnancy and lactation.</p>
]]></description>
<dc:creator><![CDATA[Sie, S. D., Wennink, J. M. B., van Driel, J. J., te Winkel, A. G. W., Boer, K., Casteelen, G., van Weissenbruch, M. M.]]></dc:creator>
<dc:date>2011-07-27T22:28:05-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.214239</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.214239</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation]]></dc:title>
<prism:publicationDate>2011-07-27</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.211318v1?rss=1">
<title><![CDATA[Growth in the neonatal period after repeat courses of antenatal corticosteroids: data from the ACTORDS randomised trial]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.211318v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To determine the effect of repeated antenatal corticosteroids on postnatal changes in weight, linear growth and head circumference.</p>
</sec>
<sec><st>Methods</st>
<p>Mothers who entered the repeated dose of antenatal steroids (ACTORDS) trial were randomised to additional weekly steroid or placebo. Infant occipital-frontal head circumference, weight and crown-heel length were measured at birth and weekly for 4 weeks or until discharge, whichever was later. Lower leg length was measured using a knemometer daily for the first week, then thrice weekly.</p>
</sec>
<sec><st>Results</st>
<p>Of 145 babies studied (77.5% of the ACTORDS study infants from this centre), 70 were exposed to repeated antenatal steroids and 75 to placebo. There were no significant differences in prerandomisation demographic and pregnancy data. The mean gestational age at ACTORDS entry was 28.7 weeks and at birth was 31.4 weeks. The mean birth weight was 1618 g. There were no significant differences in postmenstrual age, weight, length or head circumference, nor in z-scores for these measurements, at birth, 4 weeks or discharge.</p>
<p>In the first 2 weeks after birth, babies in both groups showed a decrease in z-scores for weight and length. After week 2, growth improved in both groups but babies exposed to repeat antenatal corticosteroids grew more rapidly, as measured by weight gain, increasing head circumference and increasing lower leg length knemometry. This rapid growth was most apparent around weeks 3&ndash;5 after birth.</p>
</sec>
<sec><st>Conclusion</st>
<p>Babies exposed to weekly doses of repeat antenatal corticosteroids demonstrate postnatal growth acceleration 3&ndash;5 weeks after birth.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Battin, M., Bevan, C., Harding, J.]]></dc:creator>
<dc:date>2011-07-27T22:28:04-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.211318</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.211318</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Pregnancy, Reproductive medicine]]></dc:subject>
<dc:title><![CDATA[Growth in the neonatal period after repeat courses of antenatal corticosteroids: data from the ACTORDS randomised trial]]></dc:title>
<prism:publicationDate>2011-07-27</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.213702v1?rss=1">
<title><![CDATA[The associations between ethnicity and outcomes of infants in neonatal intensive care units]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.213702v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To determine the associations between maternal ethnicity and outcomes of infants born between 22 and 31 weeks' gestation and admitted to neonatal intensive care units in New South Wales and the Australian Capital Territory, Australia, between 1995 and 2006.</p>
</sec>
<sec><st>Design and patients</st>
<p>De-identified perinatal and neonatal outcome data for 10 267 infants were examined. There were 8629 (84.0%) Caucasian, 922 (9.0%) Asian, 439 (4.3%) indigenous, 127 (1.2%) Polynesian and Maori (PAM) and 150 (1.5%) infants of other maternal ethnicities (excluded from study). Caucasians were the referent for all comparisons.</p>
</sec>
<sec><st>Results</st>
<p>Infants of indigenous mothers were less likely to receive antenatal steroids and three times as likely to be born in non-tertiary hospitals (OR 3.28, 95% CI 2.59 to 4.16, p&lt;0.001). PAM infants were more likely to have Apgar scores &lt;7 at 5 min of age (1.76, 95% CI 1.16 to 2.67, p&lt;0.01). Asian infants had lower birth weight (mean&plusmn;SD 44.7&plusmn;27.9, p&lt;0.001) and head circumference percentiles (47.8&plusmn;29.0, p&lt;0.001), were more likely to be small for gestational age (1.53, 95% CI 1.25 to 1.88, p&lt;0.001), less likely to have hyaline membrane disease (0.78, 95% CI 0.68 to 0.90, p&lt;0.001) but had a higher risk of severe retinopathy of prematurity (1.52, 95% CI 1.11 to 2.07, p&lt;0.01). Ethnicity did not influence infant mortality.</p>
</sec>
<sec><st>Conclusions</st>
<p>Neonatal growth characteristics and morbidity but not mortality are influenced by maternal ethnicity. Of concern is the risk of low Apgar scores in PAM infants and non-tertiary births of indigenous infants. Review of perinatal care for certain vulnerable ethnic populations is recommended due to the rapidly changing ethnic compositions of many countries around the world.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Ruan, S., Abdel-Latif, M. E., Bajuk, B., Lui, K., Oei, J. L., On behalf of the NSW and the ACT Neonatal Intensive Care Units (NICUs) Group]]></dc:creator>
<dc:date>2011-07-18T20:27:13-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.213702</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.213702</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Eye Diseases, Epidemiologic studies, Ophthalmology, Child health]]></dc:subject>
<dc:title><![CDATA[The associations between ethnicity and outcomes of infants in neonatal intensive care units]]></dc:title>
<prism:publicationDate>2011-07-18</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.206102v1?rss=1">
<title><![CDATA[Economic evaluation alongside the Premature Infants in Need of Transfusion randomised controlled trial]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.206102v1?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>The Premature Infants in Need of Transfusion (PINT) Outcome Study showed no significant difference in the primary outcome of death or neurodevelopmental impairment (NDI) in extremely low birthweight (ELBW) infants. However, a post-hoc analysis expanding the definition of NDI to include borderline intellectual functioning (Mental Development Index (MDI) &lt;85) found an improvement in outcomes in the group maintained at higher haemoglobin levels.</p>
</sec>
<sec><st>Objective</st>
<p>To determine the cost effectiveness of more frequent red blood cell transfusions (high-Hb threshold) compared with less frequent transfusions (low-Hb threshold) in ELBW infants.</p>
</sec>
<sec><st>Design/methods</st>
<p>The authors performed an economic evaluation using patient-level data collected during the PINT randomised trial. The authors measured comprehensive costs from a third-party payer's perspective over a time horizon from birth through 18&ndash;21 months corrected age.</p>
</sec>
<sec><st>Results</st>
<p>The average total cost in the high-Hb threshold group was CAN$149 767 compared with CAN$150 227 in the low-Hb threshold group (difference of CAN$460, p=0.96). Cost-effectiveness analysis estimated savings of CAN$6879 for every additional infant surviving without severe NDI. There was a 48% chance that the high-Hb threshold reduced costs while improving outcome and a 90% chance that it would be cost effective at a willingness-to-pay threshold of CAN$250 000 per additional survivor without severe NDI. Post-hoc analysis defining cognitive delay as MDI score &lt;85, instead of &lt;70, revealed savings in the high-Hb threshold group of CAN$4457 per additional survivor without NDI. Results were robust to deterministic sensitivity analyses.</p>
</sec>
<sec><st>Conclusion</st>
<p>A high-Hb threshold for transfusion, as measured in ELBW PINT study infants through 18 months corrected gestational age, may be an economically appealing intervention. The estimates were associated with moderate statistical uncertainty that should be targeted in larger, future studies.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Kamholz, K. L., Dukhovny, D., Kirpalani, H., Whyte, R. K., Roberts, R. S., Wang, N., Mao, W., Zupancic, J. A. F., the Premature Infants in Need of Transfusion Study Group]]></dc:creator>
<dc:date>2011-07-06T01:45:55-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.206102</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.206102</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Health policy, Clinical trials (epidemiology), Developmental paediatrics, Health economics, Health service research]]></dc:subject>
<dc:title><![CDATA[Economic evaluation alongside the Premature Infants in Need of Transfusion randomised controlled trial]]></dc:title>
<prism:publicationDate>2011-07-06</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300277v2?rss=1">
<title><![CDATA[Kasabach-Merritt syndrome in a term neonate]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300277v2?rss=1</link>
<description><![CDATA[ <p>A term infant presented with a large swelling of her left lower limb following birth (see <cross-ref type="fig" refid="F1">figure 1</cross-ref>). Investigations revealed a thrombocytopenia with normal haemoglobin and coagulation profile. Following review by the paediatric haematologist, a diagnosis of Kasabach&ndash;Merritt syndrome (KMS) was made and treatment with propranolol was commenced. However, the haemangioma increased in size and the baby remained dependent on multiple platelet transfusions. Propranolol was therefore replaced with intravenous vincristine. To date, the infant has received eight doses of vincristine. No vincristine-related side effects have been observed. She has remained independent of platelet transfusions, and the lesion has improved significantly since vincristine was commenced (see <cross-ref type="fig" refid="F2">figure 2</cross-ref>).</p> <p>KMS was first described by Haig Haigouni Kasabach and Katherine Krom Merritt in 1940. It is defined by a large haemangioma with thrombocytopenia.<cross-ref type="bib" refid="R1">1</cross-ref> In the majority of cases, it is associated with some laboratory evidence of...]]></description>
<dc:creator><![CDATA[Freeman, I., Ganesan, K., Emmerson, A. J. B.]]></dc:creator>
<dc:date>2011-06-29T02:40:17-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300277</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300277</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Kasabach-Merritt syndrome in a term neonate]]></dc:title>
<prism:publicationDate>2011-06-29</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.204735v1?rss=1">
<title><![CDATA[Prognostic value of EEG in very premature newborns]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.204735v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To evaluate the prognostic value of EEG regarding the psychomotor outcomes of very premature newborns.</p>
</sec>
<sec><st>Methods</st>
<p>76 premature infants &lt;30 weeks gestation were enrolled between January 2001 and August 2004. They were examined at 4 and 9 months corrected ages, and at 18 months, 3&ndash;4 years and 5&ndash;6 years. EEGs performed in the neonatal period were analysed by two neurologists blind to the child's outcome.</p>
</sec>
<sec><st>Results</st>
<p>The mean follow-up was 5.6 years. 25 infants had normal neurological development and all EEGs were normal for 22 of these. 36 others had developmental disabilities (7 motor sequelae and 29 delayed psychomotor development). Of 187 EEGs, 43 were dysmature, 13 disorganised, 2 displayed electrical seizures without clinical manifestations and 15 showed other abnormal features. Dysmaturity was the predominant EEG pattern in newborns with severe or moderate sequelae and was persistent on several EEGs in 12 of these. In contrast, only three infants with normal development had a dysmature pattern on one EEG. All infants with a disorganised pattern had cognitive sequelae, and two had cerebral palsy. The sensitivity of EEG regarding psychomotor outcome was 83.3%, the specificity was 88% and the positive predictive value was 90.9%.</p>
</sec>
<sec><st>Conclusions</st>
<p>Very preterm neonates remain at high risk of neurological sequelae and EEG is a sensitive method for assessing neuromotor and cognitive prognosis. A dysmature pattern was the predominant EEG characteristic in infants who developed severe or moderate impairment. Early postnatal tracing is useful but additional recordings are generally necessary to detect high-risk newborns.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Le Bihannic, A., Beauvais, K., Busnel, A., de Barace, C., Furby, A.]]></dc:creator>
<dc:date>2011-06-09T11:29:42-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.204735</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.204735</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Cerebral palsy, Epilepsy and seizures, Child and adolescent psychiatry (paedatrics), Child health, Infant health, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Prognostic value of EEG in very premature newborns]]></dc:title>
<prism:publicationDate>2011-06-09</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.199703v1?rss=1">
<title><![CDATA[Delayed cord clamping and blood flow in the superior vena cava in preterm infants: an observational study]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.199703v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To determine if timing of cord clamping affects blood flow in the upper body, as measured by flow in the superior vena cava (SVC).</p>
</sec>
<sec><st>Design</st>
<p>Observational study.</p>
</sec>
<sec><st>Setting</st>
<p>Neonatal Unit, Middlemore Hospital, Auckland, New Zealand.</p>
</sec>
<sec><st>Patients</st>
<p>30 preterm infants &lt;30 weeks' gestational age.</p>
</sec>
<sec><st>Intervention</st>
<p>Cord clamping was immediate in 17 infants and delayed by 30&ndash;45 s in 13.</p>
</sec>
<sec><st>Results</st>
<p>Infants in the two groups did not differ significantly in terms of gestational age, gender or use of antenatal steroids. Median flow in the SVC in the first 24 h was significantly higher in the group with delayed clamping (median 91 ml/kg/min; IQR 81&ndash;101) compared with 52 ml/kg/min (IQR 42&ndash;100) in the immediate clamping group (p=0.028). Fewer infants in the delayed group had low flow (1 compared with 9; p=0.017). All three infants with intraventricular haemorrhage (IVH) (of any grade) had low flow.</p>
</sec>
<sec><st>Conclusions</st>
<p>Blood flow in the SVC was higher in infants where delayed cord clamping was performed. The relationship of IVH, low flow and timing of cord clamping requires further study.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Meyer, M. P., Mildenhall, L.]]></dc:creator>
<dc:date>2011-05-17T02:07:50-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.199703</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.199703</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Infant health, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Delayed cord clamping and blood flow in the superior vena cava in preterm infants: an observational study]]></dc:title>
<prism:publicationDate>2011-05-17</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.207043v1?rss=1">
<title><![CDATA[Which growth criteria better predict fetal programming?]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.207043v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To test whether customised (ct) growth criteria are more reliable than standard (st) ones to predict intrauterine insult.</p>
</sec>
<sec><st>Patients</st>
<p>32 mothers and their singleton term neonates selected as small for gestational age (st-SGA=8) or appropriate for gestational age (st-AGA=24).</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Nitric oxide, high-sensitive C reactive protein (hs-CRP), uric acid, blood lipids and protein levels were analysed in maternal and cord blood.</p>
</sec>
<sec><st>Results</st>
<p>Applying customised criteria yielded 16 ct-AGA, 13 ct-SGA and 3 ct-LGA (large for gestational age) babies. Both st-SGA and ct-SGA babies had higher nitric oxide and hs-CRP levels. Their mothers had lower albumin fractions. st-SGA babies also had higher triglyceride and cholesterol levels. ct-LGA babies and mothers had higher uric acid levels, and the mothers had higher triglyceride levels.</p>
</sec>
<sec><st>Conclusions</st>
<p>Customised growth criteria better identify babies submitted to unfavourable intrauterine environments. The authors suggest that combined with maternal biochemistry, these growth criteria can be used to screen for adverse <I>fetal programming</I>.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Mattos, S. S., Chaves, M. E. C., Costa, S. M. R., Ishigami, A. C. M., Rego, S. B., Souto Maior, V., Severi, R., de Lima Filho, J. L.]]></dc:creator>
<dc:date>2011-03-27T23:30:09-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.207043</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.207043</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Which growth criteria better predict fetal programming?]]></dc:title>
<prism:publicationDate>2011-03-27</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.208868v1?rss=1">
<title><![CDATA[Postnatal intravenous steroids and long-term neurological outcome: recommendations from meta-analyses]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.208868v1?rss=1</link>
<description><![CDATA[
<p>Postnatal steroids have been widely used to facilitate the extubation of ventilator-dependent preterm infants. Reports published in the late 1990s and early 2000s raised concerns about their long-term impact on neurodevelopmental outcomes. Since then, postnatal steroid use has declined sharply, but they continue to be regarded by many clinicians as an essential part of neonatal care, and there is considerable confusion as to the most appropriate time to use them. This review examines the meta-analyses of the relationship between intravenous postnatal steroids and neurodevelopmental impairment, and provides recommendations for their use based upon that body of evidence.</p>
]]></description>
<dc:creator><![CDATA[Yates, H., Newell, S.]]></dc:creator>
<dc:date>2011-03-22T01:51:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.208868</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.208868</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Postnatal intravenous steroids and long-term neurological outcome: recommendations from meta-analyses]]></dc:title>
<prism:publicationDate>2011-03-22</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.194100v1?rss=1">
<title><![CDATA[Procalcitonin in detecting neonatal nosocomial sepsis]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.194100v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To investigate the accuracy of procalcitonin (PCT) as a diagnostic marker of nosocomial sepsis (NS) and define the most accurate cut-off to distinguish infected from uninfected neonates.</p>
</sec>
<sec><st>Setting</st>
<p>Six neonatal intensive care units (NICUs).</p>
</sec>
<sec><st>Patients</st>
<p>762 neonates admitted to six NICUs during a 28-month observational study for whom at least one serum sample was taken on admission.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Positive and negative predictive values at different PCT cut-off levels.</p>
</sec>
<sec><st>Results</st>
<p>The overall probability of an NS was doubled or more if PCT was &gt;0.5 ng/ml. In very-low-birth-weight (VLBW) infants, a cut-off of &gt;2.4 ng/ml gave a positive predictive value of NS near to 50% with a probability of a false-positive diagnosis of NS in about 10% of the patients.</p>
</sec>
<sec><st>Conclusions</st>
<p>In VLBW neonates, a serum PCT value &gt;2.4 ng/ml prompts early empirical antibiotic therapy, while in normal-birth-weight infants, a PCT value &le;2.4 ng/ml carries a low risk of missing an NS.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Auriti, C., Fiscarelli, E., Ronchetti, M. P., Argentieri, M., Marrocco, G., Quondamcarlo, A., Seganti, G., Bagnoli, F., Buonocore, G., Serra, G., Bacolla, G., Mastropasqua, S., Mari, A., Corchia, C., Prencipe, G., Piersigilli, F., Rava, L., Di Ciommo, V.]]></dc:creator>
<dc:date>2011-03-15T02:01:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.194100</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.194100</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Procalcitonin in detecting neonatal nosocomial sepsis]]></dc:title>
<prism:publicationDate>2011-03-15</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2009.170910v1?rss=1">
<title><![CDATA[Promoting growth for preterm infants following hospital discharge]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2009.170910v1?rss=1</link>
<description><![CDATA[
<p>Preterm infants, especially very preterm infants, are usually growth-restricted at the time of hospital discharge. Proposed interventions to promote catch-up growth following hospital discharge include multinutrient fortification of expressed breast milk for breastfed infants and nutrient-enriched formula milk for formula-fed infants. The current evidence to support these strategies is limited. Fortification of expressed breast milk may increase weight gain and skeletal and head growth during infancy, but more research is needed to define which nutrients confer most benefit, and which population of infants is likely to receive most benefit. Trials that have assessed feeding preterm infants with commercially available nutrient-enriched formula milk (&lsquo;preterm&rsquo; or &lsquo;postdischarge&rsquo; formulae) compared with standard formula milk have not found consistent evidence of an effect on growth parameters or development, probably because ad libitum fed infants reduce their intake relative to the calorie-density of the milk. Future studies should focus on the effect of formulae enriched with protein and minerals rather than energy and assess the effect on lean mass and skeletal growth.</p>
]]></description>
<dc:creator><![CDATA[Morgan, J. A., Young, L., McCormick, F. M., McGuire, W.]]></dc:creator>
<dc:date>2011-03-15T02:01:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2009.170910</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2009.170910</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Promoting growth for preterm infants following hospital discharge]]></dc:title>
<prism:publicationDate>2011-03-15</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.205864v1?rss=1">
<title><![CDATA[Designing the new UK-WHO growth charts to enhance assessment of growth around birth]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.205864v1?rss=1</link>
<description><![CDATA[
<p>The decision to adopt the new WHO standard in the UK necessitated substantial changes to the neonatal section of the chart, including separation of the preterm UK birth weight reference from the WHO standard. The evidence-based design process has led to several novel features that could be generally applied in other chart designs, and revealed uncertainties leading to inconsistencies in charting. Failing to plot the birth weight of term infants at age 0 can lead to spurious centile crossing in the early weeks of life, particularly among infants at the extreme of gestation. Users will need training to use the charts, but this should improve overall understanding and the use of charts.</p>
]]></description>
<dc:creator><![CDATA[Cole, T. J., Wright, C. M., Williams, A. F., ; RCPCH Growth Chart Expert Group]]></dc:creator>
<dc:date>2011-03-11T01:04:03-08:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.205864</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.205864</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Designing the new UK-WHO growth charts to enhance assessment of growth around birth]]></dc:title>
<prism:publicationDate>2011-03-11</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.211649v1?rss=1">
<title><![CDATA[Provision of servo-controlled cooling during neonatal transport]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.211649v1?rss=1</link>
<description><![CDATA[
<sec><st>Introduction</st>
<p>Therapeutic hypothermia is a time critical intervention for infants who have experienced a hypoxic&ndash;ischaemic event. Previously reported methods of cooling during transport do not demonstrate the same stability achieved in the neonatal unit. The authors developed a system which allowed provision of servo-controlled cooling throughout transport, and present their first year's experience.</p>
</sec>
<sec><st>Methods</st>
<p>Retrospective review of routinely collected patient data.</p>
</sec>
<sec><st>Results</st>
<p>14 out-born infants were referred for cooling during a 12-month period. Nine infants were managed with the servo-controlled system during transport. Cooling was commenced in all infants before 6 h of life. Median time from team arrival to the infant having a temperature in the target range (33&ndash;34&deg;C) was 45 min. Median temperature during transfer was 33.5&deg;C (range 33&ndash;34&deg;C). Temperature on arrival at the cooling centre ranged from 33.4&deg;C to 33.8&deg;C.</p>
</sec>
<sec><st>Conclusion</st>
<p>Servo-controlled cooling during transport is feasible and provides an optimal level of thermal control.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Johnston, E. D., Becher, J.-C., Mitchell, A. P., Stenson, B. J.]]></dc:creator>
<dc:date>2011-03-06T03:58:23-08:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.211649</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.211649</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Provision of servo-controlled cooling during neonatal transport]]></dc:title>
<prism:publicationDate>2011-03-06</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.190173v1?rss=1">
<title><![CDATA[Management of posthaemorrhagic ventricular dilatation]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.190173v1?rss=1</link>
<description><![CDATA[
<p>Intraventricular haemorrhage and posthaemorrhagic ventricular dilatation remain an important challenge in the management of prematurity and are associated with significant permanent morbidity. Progressive ventricular dilatation causes white matter injury by pressure, distortion, free radical injury and inflammation. Therapeutic interventions include serial lumbar punctures, only useful when the ventricles remain in communication with the lumbar subarachnoid space, and repeated aspiration through a ventricular access device. Reduction of cerebrospinal fluid production by acetazolamide and frusemide in a large multicentre randomised trial showed a worse outcome in the treated arm. A trial of drainage, irrigation and fibrinolytic therapy did not demonstrate a reduced need for permanent cerebrospinal fluid diversion, but did show a significant reduction in severe cognitive disability at two years. Ventriculoperitoneal shunting is indicated when the ventricles continue to enlarge at a body weight of around 2.5 kg and cerebrospinal fluid protein levels are below 1.5 g /L.</p>
<p>This review summarises current concepts on the pathophysiology and management of posthaemorrhagic ventricular dilatation, underlining clinical challenges and ongoing research.</p>
<p>Although the percentage of small preterm infants developing intraventricular haemorrhage (IVH) has been greatly reduced in the last three decades, increased survival of very immature infants has meant that large IVH with subsequent posthaemorrhagic ventricular dilatation is still a serious unsolved problem.</p>
]]></description>
<dc:creator><![CDATA[Whitelaw, A., Aquilina, K.]]></dc:creator>
<dc:date>2011-02-02T03:41:33-08:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.190173</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.190173</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Management of posthaemorrhagic ventricular dilatation]]></dc:title>
<prism:publicationDate>2011-02-02</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2009.180091v1?rss=1">
<title><![CDATA[The management of neonatal pulmonary hypertension]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2009.180091v1?rss=1</link>
<description><![CDATA[
<p>Most neonates with clinically significant pulmonary hypertension (PH) will have either persistent PH of the newborn (PPHN) or bronchopulmonary dysplasia. Cyanotic congenital heart disease must be actively ruled out as part of the differential diagnosis of PPHN. The maintenance of ductal patency with prostaglandins E1 or E2 in cases of doubt is safe and potentially beneficial given their pulmonary vasorelaxant properties. Specific tools in the treatment of PPHN include modern ventilatory strategies, inhaled nitric oxide, sildenafil, prostacyclin and extracorporeal membrane oxygenation.</p>
<p>Rarely will a cardiac lesion be primarily responsible for neonatal PH although pulmonary vein stenosis and the persistence of an arterial duct must be considered, particularly in the older preterm baby with bronchopulmonary dysplasia.</p>
]]></description>
<dc:creator><![CDATA[Dhillon, R.]]></dc:creator>
<dc:date>2011-01-30T05:17:02-08:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2009.180091</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2009.180091</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[The management of neonatal pulmonary hypertension]]></dc:title>
<prism:publicationDate>2011-01-30</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.188359v1?rss=1">
<title><![CDATA[Postnatal ultrasound reliability in cerebellar vermis assessment]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.188359v1?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Cerebellar growth in late gestation is impeded by prematurity which may adversely affect neurocognitive development. Assessment of cerebellar growth should be easily attainable, reliable and reproducible.</p>
</sec>
<sec><st>Objective</st>
<p>To assess the reliability of linear sonographic cerebellar vermis measurement.</p>
</sec>
<sec><st>Method</st>
<p>Cranial ultrasounds of 110 infants ranging from 24 to 41 weeks' gestation were retrospectively reviewed. Cerebellar vermian height, craniocaudal diameter and superior and inferior vermis widths were independently measured on the first midline sagittal image by three neonatal sonologists of varying experience. Interobserver and intraobserver reliability were calculated using the intraclass correlation coefficient (ICC) (2 way mixed model, SPSS V.15.0).</p>
</sec>
<sec><st>Results</st>
<p>61 images were technically adequate. Interobserver ICCs (95% CI) were: cerebellar vermian height 0.88 (0.82 to 0.92); craniocaudal diameter 0.91 (0.86 to 0.94); superior vermis width 0.84 (0.77 to 0.89); inferior vermis width 0.92 (0.89 to 0.95). Intraobserver ICCs were similar.</p>
</sec>
<sec><st>Conclusion</st>
<p>With adequate images, linear ultrasound measurements of cerebellar vermis are reliable.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Armstrong, R. K., Fox, L. M., Cheong, J. L. Y., Davis, P. G., Rogerson, S. K.]]></dc:creator>
<dc:date>2011-01-17T04:15:52-08:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.188359</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.188359</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Postnatal ultrasound reliability in cerebellar vermis assessment]]></dc:title>
<prism:publicationDate>2011-01-17</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.190157v1?rss=1">
<title><![CDATA[Meconium obstruction of prematurity]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.190157v1?rss=1</link>
<description><![CDATA[
<p>Meconium obstruction of prematurity is an entity primarily affecting very low birthweight or extremely low birthweight babies causing low intestinal obstruction. Its presence may at best delay establishment of enteral feeding and compromise nutrition and at worst lead to mechanical obstruction requiring surgery or to intestinal perforation. There are considerable challenges in the recognition, diagnosis and management of this condition. Awareness of the disease and understanding of its pathogenesis may lead to early detection of affected babies and allow proactive measures to decrease the associated morbidity and mortality.</p>
]]></description>
<dc:creator><![CDATA[Siddiqui, M. M. F., Drewett, M., Burge, D. M.]]></dc:creator>
<dc:date>2010-11-29T01:16:59-08:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.190157</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.190157</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Meconium obstruction of prematurity]]></dc:title>
<prism:publicationDate>2010-11-29</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2009.175109v1?rss=1">
<title><![CDATA[Assessment of myocardial function in neonates using tissue Doppler imaging]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2009.175109v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To measure the left and right ventricular myocardial velocities using tissue Doppler imaging (TDI) in the first 24 h of life in neonates.</p>
</sec>
<sec><st>Design</st>
<p>Left and right ventricular peak systolic (S'), early diastolic (E') and late diastolic (A') myocardial velocities were measured using TDI alongside standard echocardiography (including peak diastolic atrioventricular flow, E). E/E' ratio was calculated for both ventricles.</p>
</sec>
<sec><st>Setting</st>
<p>UK neonatal intensive care unit.</p>
</sec>
<sec><st>Patients</st>
<p>43 neonates were prospectively recruited into three groups: term (n=16), preterm (30&ndash;36 weeks, n=12) and very preterm (&lt;30 weeks, n=15).</p>
</sec>
<sec><st>Results</st>
<p>Myocardial velocities increased with increasing gestation. Right ventricular velocities were significantly greater than left. E/E' ratio decreased with increasing gestation. Left E/E' ratio was higher than right in each group.</p>
</sec>
<sec><st>Conclusions</st>
<p>TDI is feasible in preterm neonates and enables the acquisition of myocardial velocities. With increasing gestation, higher myocardial velocities and lower E/E' ratios were found. The addition of TDI to standard neonatal echocardiography may provide additional information about cardiac function.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Negrine, R. J. S., Chikermane, A., Wright, J. G. C., Ewer, A. K.]]></dc:creator>
<dc:date>2010-10-30T05:27:17-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2009.175109</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2009.175109</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Assessment of myocardial function in neonates using tissue Doppler imaging]]></dc:title>
<prism:publicationDate>2010-10-30</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2007.120709v1?rss=1">
<title><![CDATA[Improving antibiotic prescribing in neonatal units: time to act]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2007.120709v1?rss=1</link>
<description><![CDATA[
<p>Antibiotics are increasingly prescribed in the peripartum period, for both maternal and fetal indications. Their effective use can be life-saving, however, injudicious use drives antibiotic resistance and contributes to the development of abnormal faecal flora and subsequent immune dysregulation. Neonatal units are a high risk area for the selection and transmission of multi-resistant organisms. Very few new antibiotics with activity against Gram-negative bacteria are under development, and no significantly new Gram-negative antibiotics will be available in the next decade. This review seeks to summarise current practice, and suggests restrictive antibiotic strategies based on epidemiological data from recently published UK neonatal infection surveillance studies.</p>
]]></description>
<dc:creator><![CDATA[Russell, A. B., Sharland, M., Heath, P. T.]]></dc:creator>
<dc:date>2010-10-30T05:27:17-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2007.120709</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2007.120709</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Improving antibiotic prescribing in neonatal units: time to act]]></dc:title>
<prism:publicationDate>2010-10-30</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.183863v1?rss=1">
<title><![CDATA[Congenital syphilis in Italy: a multicentre study]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.183863v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To study the prevalence of congenital syphilis and its risk factors in Italy.</p>
</sec>
<sec><st>Study design</st>
<p>Prospective study from 1 July 2006 to 30 June 2007. Data on mother&ndash;child pairs were collected for every syphilis seropositive mother.</p>
</sec>
<sec><st>Results</st>
<p>Maternal syphilis seroprevalence at delivery was 0.17%. 207 infants were born to 203 syphilis seropositive mothers. In 25 newborns it was possible to diagnose congenital syphilis (20/100 000 live births). Maternal risk factors included age &lt;20 years, no antenatal care and no adequate treatment. The infected babies were more often preterm or weighed &lt;2000 g at birth.</p>
</sec>
<sec><st>Discussion</st>
<p>Many syphilis seropositive mothers were foreign born but the risk of an infected newborn was not higher in foreign-born than in Italian seropositive women. The significant factors were lack of antenatal screening and inadequate maternal treatment.</p>
</sec>
<sec><st>Conclusion</st>
<p>Syphilis is a re-emerging infection in Italy. Prevention strategies should include antenatal serological tests for all pregnant women and treatment for infected mothers.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Tridapalli, E., Capretti, M. G., Reggiani, M. L. B., Stronati, M., Faldella, G., The Italian Neonatal Task Force of Congenital Syphilis for The Italian Society of Neonatology - Collaborative Group]]></dc:creator>
<dc:date>2010-09-24T09:37:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.183863</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.183863</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Congenital syphilis in Italy: a multicentre study]]></dc:title>
<prism:publicationDate>2010-09-24</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2009.178723v1?rss=1">
<title><![CDATA[Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2009.178723v1?rss=1</link>
<description><![CDATA[
<p>It is widely accepted that maternal drug-exposed infants demonstrate excessive early weight loss, but this has not previously been quantified. Among 354 term, substitute methadone-exposed infants, median maximal weight losses were 10.2% and 8.5% for breast- and formula-fed infants, respectively (p=0.003). Weight loss was less in small for gestational age compared to appropriately grown infants (p&lt;0.001). There was no association between maximal weight loss and plasma sodium concentration (p=0.807). Relative to non-drug exposed infants, weight loss was more marked in formula-fed infants, 48% of whom demonstrated weight loss in excess of the 95th centile (compared to 23% of exclusively breastfed infants; p&lt;0.001). Median weight loss nadir was on day 5, excepting those infants exclusively breastfed (day 4). These data suggest that excessive neonatal weight loss among breastfed infants of drug-misusing mothers does not necessarily reflect poorly established lactation and may help to guide management of breast feeding in this population.</p>
]]></description>
<dc:creator><![CDATA[Dryden, C., Young, D., Campbell, N., Mactier, H.]]></dc:creator>
<dc:date>2010-07-23T01:37:54-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2009.178723</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2009.178723</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding]]></dc:title>
<prism:publicationDate>2010-07-23</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2009.180869v1?rss=1">
<title><![CDATA[Book review]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2009.180869v1?rss=1</link>
<description><![CDATA[ <p>Neonatology, it is said, is 10% emergencies and 90% waiting for those emergencies to happen. The unpredictable nature and timing of those emergencies means that senior skilled help is not always available immediately. <I>Neonatal Emergencies</I>, edited by Georg Hansmann, is written by experts from North America and Europe and constitutes a useful mix of readily accessible information covering emergencies that occur in the first 72 h of life (and sometimes beyond).</p> <p>It is, it must be said, not the only book of its kind on the market and most of us will have used at least one of the rival <I>Neonatal Handbooks</I> in the past (and probably become familiar with the layout of our favourites in doings so as they update themselves with new editions). As a new, and therefore unfamiliar, book it will need to offer something more to attract a readership and gain a good reputation. Fortunately,...]]></description>
<dc:creator><![CDATA[Ainsworth, S. B.]]></dc:creator>
<dc:date>2010-06-14T01:27:10-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2009.180869</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2009.180869</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Book review]]></dc:title>
<prism:publicationDate>2010-06-14</prism:publicationDate>
<prism:section>Postscript</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2008.137125v1?rss=1">
<title><![CDATA[Management of infantile spasms in a regional centre before and after the United Kingdom Infantile Spasms Study (UKISS)]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2008.137125v1?rss=1</link>
<description><![CDATA[
<p><P>The United Kingdom Infantile Spasms Study (UKISS) comparing hormonal treatment against vigabatrin in the management of infantile spasms showed that cessation of spasms was more likely in infants given hormonal treatment. </P>
<P>We believe this study has changed our practice and the advice we give colleagues across our region regarding the management of infantile spasms. We undertook this audit to see if this was confirmed.</P>
]]></description>
<dc:creator><![CDATA[Maheshwari, N., Zaiwalla, Z., McShane, M A]]></dc:creator>
<dc:date>2008-02-05T08:53:54-08:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2008.137125</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2008.137125</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Management of infantile spasms in a regional centre before and after the United Kingdom Infantile Spasms Study (UKISS)]]></dc:title>
<prism:publicationDate>2008-02-05</prism:publicationDate>
<prism:section>Letters</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2006.114009v1?rss=1">
<title><![CDATA[The impact of maternal micronutrient supplementation on early neonatal morbidity in rural Nepal: a randomized, controlled, community trial]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2006.114009v1?rss=1</link>
<description><![CDATA[
<p><P><B>Objective:</B> Micronutrient deficiencies during pregnancy may be linked to poor newborn health and host defenses against infection. We assessed newborn morbidity to determine the impact of four combinations of antenatal micronutrient supplements.
</P>
<P>
<B>Design:</B> Cluster-randomized, double-masked, controlled trial.  
</P>
<P>
<B>Setting:</B> Rural community in Nepal.
</P>
<P>
<B>Interventions:</B> Women received daily supplements from early pregnancy through 3 months postpartum of vitamin A alone (control) or vitamin A with folic acid, folic acid + iron, folic acid + iron  + zinc or a multiple micronutrient supplement containing these and 11 other nutrients. 
</P>
<P>
<B>Main outcome measures:</B> Infants were visited in their home at birth (n=3927) and for each of 9 days thereafter to elicit a 24-h history of 9 infant morbidity symptoms, measure infant respiratory rate and axial temperature, and assess the infant for chest indrawing. At 6 weeks of age, infants were visited again in their homes to elicit a 30-day and 7-day history of 10 morbidity symptoms using parental recall. 
</P>
<P>
<B>Results:</B> Maternal micronutrient supplementation had no impact on 10-d morbidity or morbidity 30-d and 7-d morbidity assessed at 6 wk of age; all relative risks were close to 1. Symptoms of birth asphyxia increased by about 60% (p&lt;0.05) in infants of women who received the multiple micronutrient supplement compared to the control.  Symptoms of combinations of sepsis, preterm, and birth asphyxia were associated with 8-14-fold increased odds of 6-mo infant mortality.  
</P>
<P>
<B>Conclusions:</B> None of the combinations of antenatal micronutrient supplements tested improved symptoms of neonatal morbidity in the first 10 days of life or at 6 weeks of age. Further research is needed to elucidate the association and mechanism of increased risk of birth asphyxia following maternal multiple micronutrient supplementation.</P>
]]></description>
<dc:creator><![CDATA[Christian, P. S, Darmstadt, G. L, Wu, L., Khatry, S. K, LeClerq, S. C, Katz, J., West, K. P, Adhikari, R. K]]></dc:creator>
<dc:date>2007-08-03T05:57:57-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2006.114009</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2006.114009</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[The impact of maternal micronutrient supplementation on early neonatal morbidity in rural Nepal: a randomized, controlled, community trial]]></dc:title>
<prism:publicationDate>2007-08-03</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2006.105577v1?rss=1">
<title><![CDATA[High prevalence of vitamin D deficiency in newborns of high-risk mothers]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2006.105577v1?rss=1</link>
<description><![CDATA[
<p><P><B>Objective:</B> To determine the prevalence of vitamin D deficiency in newborn infants of mothers at risk of vitamin D deficiency because of dark skin or the wearing of concealing clothes (such as a veil), compared with a group supposed not to be at risk. A second aim was to correlate these newborns&rsquo; vitamin D concentrations to biochemical parameters of vitamin D metabolism and bone turnover at birth. 
</P>
<P>
<B>Design:</B> A prospective study conducted between April 2004 and February 2006 including women delivering in this period, and their newborns.
</P>
<P>
<B>Setting:</B> Outpatient clinic of the obstetrics department, Sint Franciscus Gasthuis, Rotterdam, the Netherlands.
</P>
<P>
<B>Patients:</B> Eighty-seven newborns of healthy mothers either with dark skin and/or concealing clothing (risk group) or with light skin (control group).
</P>
<P>
<B>Results:</B> We found a significant difference in the prevalence of vitamin D deficiency (25-hydroxyvitamin D3 &lt; 25 nmol/l) between newborns born to mothers at risk and newborns born to mothers in the control group (63.3% vs. 15.8%; p&lt;0.0001). Mean alkaline phosphatase concentrations were significantly higher in the risk group.
</P>
<P>
<B>Conclusions:</B> Newborn infants of mothers with dark skin or of mothers wearing concealing clothes are at great risk of vitamin D deficiency at birth. Clinical implications are unknown. Further research is necessary to determine the long-term consequences of maternal and neonatal vitamin D deficiency in order to issue guidelines on vitamin D supplementation during pregnancy.</P>
]]></description>
<dc:creator><![CDATA[Dijkstra, S.H., van Beek, A., Janssen, J.W., de Vleeschouwer, L.H.M., Huysman, W.A., van den Akker, E.L.T.]]></dc:creator>
<dc:date>2007-04-25T07:53:37-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2006.105577</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2006.105577</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[High prevalence of vitamin D deficiency in newborns of high-risk mothers]]></dc:title>
<prism:publicationDate>2007-04-25</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
</rdf:RDF>
